To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NFS1andCPNE1andRBM12TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
1320 representative clones for gene NFS1andCPNE1andRBM12 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA319853 hippocampus .a 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
DB081250 testis .a 2 to 477 2 to 477   capped   476/476
(100 %)
2 diff
(99.6 %id)
DA493601 brain .a 3 to 500 2 to 500   capped   499/499
(100 %)
1 diff
(99.8 %id)
DA339541 hippocampus .a 25 to 601 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA415766 thalamus .a 27 to 571 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA712021   .a 33 to 571 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA887908   .a 33 to 571 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB234828 trachea .a 33 to 611 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CD652058 Embryonic Stem cells .a 34 to 743 1 to 709       709/782
(90 %)
14 diff
(98.3 %id)
DA854875 placenta .a 34 to 622 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DB222534 trachea .a 34 to 638 2 to 607   capped   606/606
(100 %)
2 diff
(99.7 %id)
DA106476 cerebellum .a 38 to 571 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
BX403476 placenta .a 44 to 1072 1 to 1020   tiling clone,   1020/1050
(97 %)
21 diff
(98.0 %id)
BX411550 placenta .a 2864 to 3478 616 to 1   tiling clone,   616/879
(70 %)
23 diff
(97.4 %id)
DA726337   .b 1 to 560 2 to 561   tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
DB229718 trachea .b 5 to 589 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
AB018308 brain .b 16 to 5347 1 to 5332 exact tiling clone, available from KIAA,   5332/5332
(100 %)
0 diff
(100 %id)
DB091531 testis .c 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
NM_152838.2   .c 21 to 6609 1 to 6589 exact RefSeq, AAA   6589/6589
(100 %)
0 diff
(100 %id)
DB081243 testis .c 31 to 577 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB163638 thymus .c 31 to 619 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA458035 tongue, tumor tissue .c 32 to 562 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
AK092239   .c 37 to 3805 1 to 3769 exact available from FLJ,   3769/3769
(100 %)
2 diff
(100.0 %id)
DA660192   .c 37 to 609 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA113160 cerebellum .c 38 to 636 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA724170   .c 38 to 491 2 to 455   capped   454/454
(100 %)
0 diff
(100 %id)
DA740505   .c 38 to 536 2 to 502   capped   501/503
(99 %)
3 diff
(99.5 %id)
DA742389   .c 38 to 514 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DA781074 brain .c 38 to 537 2 to 501   capped   500/500
(100 %)
0 diff
(100 %id)
DA807011 brain .c 38 to 585 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB291062 uterus .c 38 to 612 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA858343 placenta .c 39 to 684 2 to 647   capped   646/646
(100 %)
0 diff
(100 %id)
DB001951 breast, tumor tissue .c 43 to 537 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DB218024 trachea .c 43 to 472 2 to 431   capped   430/430
(100 %)
0 diff
(100 %id)
AF393214   .c 57 to 4117 1 to 4062 exact     4062/4065
(99 %)
2 diff
(100.0 %id)
CN371882 embryonic stem cells, cell lines H1, H7, andH9 .c 57 to 742 1 to 686       686/686
(100 %)
2 diff
(99.8 %id)
AJ289772   .c 175 to 3551 1 to 3377 S601T AAA   3377/3377
(100 %)
1 diff
(100.0 %id)
BE929876 placenta_normal .c 175 to 551 377 to 1       377/378
(99 %)
1 diff
(99.8 %id)
AL833222 lymph node .c 187 to 5248 1 to 5062 exact tiling clone, available from DKFZ, AAA   5062/5062
(100 %)
1 diff
(100.0 %id)
DA414185 thalamus .c 224 to 797 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BQ223831 melanotic melanoma, skin .c 228 to 1038 27 to 846       820/923
(88 %)
13 diff
(98.6 %id)
TI_1948087600   .c 251 to 1122 135 to 1021       887/1443
(61 %)
21 diff
(98.6 %id)
TI_1948087763   .c 251 to 1239 132 to 1124       993/1379
(72 %)
34 diff
(97.6 %id)
TI_1948087939   .c 251 to 1309 134 to 1198       1065/1355
(78 %)
59 diff
(95.7 %id)
TI_1948088114   .c 251 to 1154 131 to 1046       916/1385
(66 %)
29 diff
(98.0 %id)
CN371872 embryonic stem cells, cell lines H1, H7, andH9 .c 268 to 935 1 to 668       668/668
(100 %)
2 diff
(99.8 %id)
DR158344 human embryonic stem cells differentiated toan early endodermal cell type .c 292 to 976 1 to 685       685/685
(100 %)
6 diff
(99.2 %id)
DA116844 cerebellum .c 391 to 943 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BM800770 melanotic melanoma, skin .c 403 to 1207 1 to 807       807/1021
(79 %)
13 diff
(98.8 %id)
DA817187   .c 417 to 989 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB163100 thymus .c 421 to 1014 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
CN371891 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 423 to 1075 1 to 653       653/653
(100 %)
0 diff
(100 %id)
BF083138 colon_est .c 436 to 773 343 to 4       340/343
(99 %)
0 diff
(100 %id)
BF912018 uterus_tumor .c 437 to 836 415 to 15     Submitted on the opposite strand 401/415
(96 %)
0 diff
(100 %id)
BF911332 uterus_tumor .c 449 to 836 402 to 15     Submitted on the opposite strand 388/402
(96 %)
0 diff
(100 %id)
DB223308 trachea .c 460 to 1026 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BF912019 uterus_tumor .c 461 to 836 390 to 15     Submitted on the opposite strand 376/390
(96 %)
0 diff
(100 %id)
BQ380596 uterus_tumor .c 470 to 836 381 to 15       367/381
(96 %)
0 diff
(100 %id)
AK026963   .c 591 to 3801 1 to 3211   available from FLJ, AAA   3211/3211
(100 %)
1 diff
(100.0 %id)
CN371870 embryonic stem cells, cell lines H1, H7, andH9 .c 604 to 965 1 to 362       362/362
(100 %)
0 diff
(100 %id)
AI902615 breast .c 669 to 924 256 to 1       256/256
(100 %)
0 diff
(100 %id)
BU171523 melanotic melanoma, skin .c 674 to 1543 1 to 884       884/887
(99 %)
17 diff
(98.1 %id)
BF797408 lymph, lymphoma, cell line .c 694 to 1505 1 to 811       811/1062
(76 %)
21 diff
(98.1 %id)
CU454999 epidermis .c 717 to 1455 5 to 743       739/743
(99 %)
6 diff
(99.2 %id)
CX869905 embryonic stem .c 725 to 1343 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BF026158 melanotic melanoma, skin .c 731 to 1493 1 to 752       752/916
(82 %)
16 diff
(98.3 %id)
CN371875 embryonic stem cells, cell lines H1, H7, andH9 .c 801 to 1534 1 to 734       734/734
(100 %)
2 diff
(99.8 %id)
DA506763 brain .c 885 to 1458 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
CN371876 embryonic stem cells, cell lines H1, H7, andH9 .c 901 to 1606 1 to 706       706/706
(100 %)
0 diff
(100 %id)
CN371893 embryonic stem cells, cell lines H1, H7, andH9 .c 908 to 1080 1 to 173       173/173
(100 %)
0 diff
(100 %id)
BE743593 adenocarcinoma cell line, ovary .c 937 to 1616 1 to 678       678/682
(99 %)
7 diff
(99.0 %id)
CN371886 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 961 to 1420 1 to 460       460/460
(100 %)
0 diff
(100 %id)
CD657091 Embryonic Stem cells .c 1025 to 1839 12 to 822       811/827
(98 %)
9 diff
(99.0 %id)
AL834472 melanoma (MeWo cell line) .c 1059 to 3551 1 to 2493   available from DKFZ, AAA   2493/2493
(100 %)
0 diff
(100 %id)
BG179044 adenocarcinoma, cell line, Prostate .c 1095 to 1775 1 to 676       676/969
(69 %)
11 diff
(98.9 %id)
BG387520 embryonal carcinoma, cell line, testis .c 1182 to 1888 1 to 709       709/978
(72 %)
19 diff
(98.1 %id)
AK074945   .c 1216 to 3551 1 to 2336   available from FLJ,   2336/2336
(100 %)
2 diff
(100.0 %id)
CN371877 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1228 to 1854 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BM463916 melanotic melanoma, skin .c 1268 to 2310 1 to 1044       1044/1111
(93 %)
40 diff
(96.4 %id)
BM453047 leiomyosarcoma, uterus .c 1277 to 2095 1 to 825       825/964
(85 %)
11 diff
(98.9 %id)
BF764595 colon_est .c 1317 to 1664 355 to 10     Submitted on the opposite strand 346/355
(97 %)
0 diff
(100 %id)
BM788729 stomach .c 1346 to 1999 1 to 654       654/654
(100 %)
0 diff
(100 %id)
DA046833   .c 1359 to 2100 2 to 743   capped   742/744
(99 %)
5 diff
(99.4 %id)
BG013377 placenta_normal .c 1484 to 1806 323 to 1       323/323
(100 %)
0 diff
(100 %id)
BQ050881 leiomyosarcoma, uterus .c 1493 to 2315 1 to 830       830/1047
(79 %)
17 diff
(98.4 %id)
BE838765 prostate_normal .c 1515 to 1874 359 to 1       359/359
(100 %)
8 diff
(97.8 %id)
DA381807 thalamus .c 1529 to 2089 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AU253229 neuroblastoma .c 1586 to 2266 1 to 682       682/682
(100 %)
10 diff
(98.6 %id)
DB004163 breast, tumor tissue .c 1586 to 2131 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AA325243 brain, cerebellum .c 1665 to 1904 1 to 240       240/240
(100 %)
0 diff
(100 %id)
CD643928 Embryonic Stem cells .c 1711 to 2431 12 to 730       719/820
(87 %)
11 diff
(98.7 %id)
CN371880 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1758 to 2117 1 to 360       360/360
(100 %)
0 diff
(100 %id)
BU179021 leiomyosarcoma, uterus .c 1776 to 2645 12 to 892       881/913
(96 %)
15 diff
(98.4 %id)
DA311532 hippocampus .c 1777 to 2335 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BQ651216 hepatocellular carcinoma, cell line, Liver .c 1786 to 2618 49 to 906       858/960
(89 %)
41 diff
(95.8 %id)
CR976727 T-Lymphocytes .c 1798 to 2552 1 to 759       759/759
(100 %)
4 diff
(99.5 %id)
AA496832   .c 1837 to 2079 1 to 243       243/243
(100 %)
0 diff
(100 %id)
BG109364 Bone, osteosarcoma, cell line .c 1841 to 2617 1 to 768       768/909
(84 %)
15 diff
(98.4 %id)
TI_1948087601   .c 1872 to 3054 1315 to 124       1192/1334
(89 %)
0 diff
(100 %id)
BE544980 cervical carcinoma cell line, cervix .c 1876 to 2639 1 to 758       758/876
(86 %)
24 diff
(97.3 %id)
BG767246 melanotic melanoma, high MDR (cell line), skin .c 1896 to 1964 788 to 859       777/860
(90 %)
33 diff
(96.2 %id)
AB015336 brain .c 1921 to 3356 1 to 1436       1436/1436
(100 %)
0 diff
(100 %id)
DA018985   .c 1925 to 2482 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BM917871 blood, natural killer cells, cell line .c 1944 to 2568 1 to 625       625/1121
(55 %)
2 diff
(99.9 %id)
BQ439834 melanotic melanoma, skin .c 1945 to 2678 11 to 750       740/918
(80 %)
6 diff
(99.4 %id)
BG680162 skin, squamous cell carcinoma .c 1959 to 2860 1 to 879       879/882
(99 %)
37 diff
(95.9 %id)
CX760314 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1974 to 2718 1 to 735     Submitted on the opposite strand 735/829
(88 %)
13 diff
(98.5 %id)
TI_1948088115   .c 1976 to 3054 1194 to 119       1076/1317
(81 %)
0 diff
(100 %id)
CB123645 Liver .c 1988 to 2578 1 to 591       591/591
(100 %)
0 diff
(100 %id)
DB162971 thymus .c 2006 to 2599 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
CN371879 embryonic stem cells, cell lines H1, H7, andH9 .c 2037 to 2593 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DA732776   .c 2042 to 2710 2 to 671   capped   670/678
(98 %)
4 diff
(99.5 %id)
CN371874 embryonic stem cells, cell lines H1, H7, andH9 .c 2052 to 2765 1 to 719       719/719
(100 %)
4 diff
(99.5 %id)
BG742549 skin .c 2052 to 2902 1 to 842       842/843
(99 %)
12 diff
(98.6 %id)
TI_1948087764   .c 2053 to 3054 1121 to 121       1001/1321
(75 %)
0 diff
(100 %id)
TI_1948087940   .c 2067 to 3054 1107 to 123       985/1326
(74 %)
0 diff
(100 %id)
BG249876 hypernephroma, cell line, Kidney .c 2084 to 2743 1 to 649       649/879
(73 %)
14 diff
(98.5 %id)
CD105204 brain, Pituitary .c 2090 to 2931 1 to 852       852/859
(99 %)
17 diff
(98.1 %id)
CD106280 brain, Pituitary .c 2127 to 2881 1 to 761       761/897
(84 %)
15 diff
(98.4 %id)
CN371889 embryonic stem cells, DMSO-treated H9 cellline .c 2128 to 2643 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BQ226203 melanotic melanoma, skin .c 2130 to 2965 1 to 853       853/890
(95 %)
29 diff
(96.8 %id)
BE742693 adenocarcinoma cell line, ovary .c 2135 to 2837 1 to 696       696/703
(99 %)
12 diff
(98.3 %id)
BE740926 adenocarcinoma cell line, ovary .c 2135 to 2939 1 to 794       794/949
(83 %)
21 diff
(97.8 %id)
BI091889 cervix .c 2197 to 2941 1 to 747       747/747
(100 %)
6 diff
(99.2 %id)
CR979859 T-Lymphocytes .c 2482 to 3328 1 to 853       853/862
(98 %)
8 diff
(99.1 %id)
BQ424718 eye, retinoblastoma .c 2513 to 3232 1 to 728       728/803
(90 %)
16 diff
(98.1 %id)
BI093663 cervix .c 2580 to 3381 1 to 797       797/804
(99 %)
13 diff
(98.4 %id)
BE883130 leiomyosarcoma, uterus .c 2596 to 2910 1 to 315       315/315
(100 %)
0 diff
(100 %id)
BF313897 brain, neuroblastoma .c 2650 to 3387 1 to 731       731/919
(79 %)
23 diff
(97.5 %id)
TI_227714958   .c 2692 to 3551 943 to 96   AAA   848/992
(85 %)
17 diff
(98.3 %id)
TI_154045214   .c 2710 to 3551 929 to 96   AAA   834/965
(86 %)
17 diff
(98.3 %id)
TI_227712692   .c 2715 to 3551 919 to 91   AAA   829/979
(84 %)
13 diff
(98.7 %id)
TI_154103450   .c 2733 to 3549 902 to 86   AAA   817/984
(83 %)
10 diff
(99.0 %id)
BF895966 marrow .c 2781 to 2984 240 to 40     Submitted on the opposite strand 201/249
(80 %)
0 diff
(100 %id)
CD365391 Alveolar Macrophage, lung .c 2812 to 3551 757 to 19   AAA   739/739
(100 %)
1 diff
(99.9 %id)
CK725112 Chondrosarcoma, Left Pubic Bone .c 2816 to 3549 750 to 17   AAA   734/734
(100 %)
0 diff
(100 %id)
DA034380   .c 2825 to 3360 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
BU624049 cell lines, Enchondroma .c 2847 to 3551 716 to 17   AAA   700/700
(100 %)
7 diff
(99.0 %id)
CA445040 lung, Metastatic Chondrosarcoma .c 2848 to 3551 715 to 17   AAA   699/699
(100 %)
5 diff
(99.3 %id)
BU619332 cell lines, Chondrosarcoma .c 2848 to 3554 718 to 19   AAA   700/700
(100 %)
9 diff
(98.8 %id)
AU253230 neuroblastoma .c 2866 to 3551 700 to 15   AAA   686/686
(100 %)
1 diff
(99.9 %id)
BM757881 Ascites, stomach .c 2873 to 3344 1 to 472       472/472
(100 %)
0 diff
(100 %id)
AA040637 uterus .c 2883 to 3340 1 to 463   fully sequenced,   463/463
(100 %)
6 diff
(98.8 %id)
CA412053 Chondrosarcoma Grade II, Left Pelvis .c 2887 to 3551 683 to 19   AAA   665/665
(100 %)
0 diff
(100 %id)
BM769655 stomach .c 2889 to 3547 1 to 658       658/658
(100 %)
1 diff
(99.9 %id)
AA428046   .c 2893 to 3187 1 to 295   fully sequenced,   295/295
(100 %)
2 diff
(99.4 %id)
CD367197 Alveolar Macrophage, lung .c 2902 to 3551 666 to 17   AAA   650/650
(100 %)
0 diff
(100 %id)
CD657350 Embryonic Stem cells .c 2988 to 3807 1 to 817       817/819
(99 %)
6 diff
(99.3 %id)
CA313148 Human Lung Epithelial cells, lung .c 3083 to 3805 740 to 19   AAA   722/722
(100 %)
1 diff
(99.9 %id)
CB528563 Aveolar Macrophage, lung .c 3089 to 3801 727 to 19   AAA   709/710
(99 %)
5 diff
(99.3 %id)
BF510769   .c 3103 to 3801 716 to 18   AAA   699/699
(100 %)
0 diff
(100 %id)
CN371890 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3113 to 3750 9 to 646       638/646
(98 %)
6 diff
(99.1 %id)
DA525387 brain .c 3121 to 3679 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AW473483 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 3124 to 3551 442 to 15   AAA   428/428
(100 %)
0 diff
(100 %id)
AI290013 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 3130 to 3555 426 to 1       426/426
(100 %)
0 diff
(100 %id)
BM665445 eye, optic nerve .c 3136 to 3801 684 to 19   AAA   666/666
(100 %)
0 diff
(100 %id)
AA427948   .c 3157 to 3555 399 to 1   fully sequenced,   399/399
(100 %)
4 diff
(99.0 %id)
AA774692   .c 3171 to 3552 382 to 1       382/382
(100 %)
0 diff
(100 %id)
DA800678 brain .c 3182 to 3732 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BG110580 Bone, osteosarcoma, cell line .c 3188 to 3549 1 to 362   AAA   362/362
(100 %)
0 diff
(100 %id)
D51577   .c 3213 to 3567 1 to 355       355/355
(100 %)
0 diff
(100 %id)
D51661   .c 3213 to 3536 1 to 324       324/324
(100 %)
0 diff
(100 %id)
D51935   .c 3213 to 3592 1 to 380       380/380
(100 %)
0 diff
(100 %id)
D51957   .c 3213 to 3654 1 to 442       442/442
(100 %)
0 diff
(100 %id)
D51983   .c 3213 to 3537 1 to 325       325/325
(100 %)
0 diff
(100 %id)
CN371888 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3230 to 3791 1 to 562       562/562
(100 %)
0 diff
(100 %id)
BF084273 colon .c 3271 to 3627 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AA677513 whole brain .c 3271 to 3551 296 to 16   AAA   281/281
(100 %)
0 diff
(100 %id)
AV654035 corresponding non cancerous liver tissue .c 3273 to 3555 1 to 283   AAA Submitted on the opposite strand 283/283
(100 %)
0 diff
(100 %id)
T34853 brain .c 3280 to 3551 1 to 272       272/272
(100 %)
0 diff
(100 %id)
AA813035   .c 3282 to 3551 282 to 13   AAA   270/270
(100 %)
0 diff
(100 %id)
BF084305 colon .c 3288 to 3638 358 to 8       351/358
(98 %)
0 diff
(100 %id)
BF084306 colon .c 3290 to 3638 356 to 8       349/356
(98 %)
0 diff
(100 %id)
AA496874   .c 3295 to 3802 511 to 4       508/511
(99 %)
0 diff
(100 %id)
AA045514 uterus .c 3310 to 3551 242 to 1   fully sequenced,   242/242
(100 %)
0 diff
(100 %id)
AI220701 placenta .c 3328 to 3551 248 to 25   AAA   224/224
(100 %)
0 diff
(100 %id)
BE177707 head_neck .c 3383 to 4047 669 to 7     Submitted on the opposite strand 663/669
(99 %)
0 diff
(100 %id)
FN057274 breast carcinoma .c 3404 to 3505 102 to 1     Submitted on the opposite strand 102/102
(100 %)
0 diff
(100 %id)
BM724344 eye, fetal eye .c 3434 to 4130 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
AI474397 Prostate .c 3488 to 3802 315 to 1       315/315
(100 %)
0 diff
(100 %id)
CR624522 Neuroblastoma Cot 25-normalized .c 3551 to 6589 1 to 3039   tiling clone,   3039/3039
(100 %)
0 diff
(100 %id)
BX344856 Neuroblastoma Cot 25-normalized .c 3551 to 4467 1 to 917       917/917
(100 %)
2 diff
(99.8 %id)
BX353182 Neuroblastoma Cot 25-normalized .c 3551 to 4522 1 to 961       961/1048
(91 %)
17 diff
(98.4 %id)
AI810016 pooled .c 3567 to 4116 565 to 16   AAA   550/550
(100 %)
0 diff
(100 %id)
DB324670   .c 3611 to 3805 195 to 1       195/195
(100 %)
0 diff
(100 %id)
BG687303 lung, mucoepidermoid carcinoma .c 4185 to 4939 1 to 761       761/827
(92 %)
33 diff
(96.1 %id)
BE169892 head_neck .c 4188 to 4369 182 to 1     Submitted on the opposite strand 182/182
(100 %)
3 diff
(98.4 %id)
TI_154150612   .c 4210 to 5008 80 to 873       794/794
(100 %)
25 diff
(96.9 %id)
BU620567 cell lines, Chondrosarcoma .c 4281 to 4971 709 to 19   AAA   691/691
(100 %)
3 diff
(99.6 %id)
BX502887 Liver .c 4289 to 4956 1 to 667       667/667
(100 %)
2 diff
(99.8 %id)
BM767384 Ascites, stomach .c 4300 to 4840 1 to 541       541/541
(100 %)
0 diff
(100 %id)
BX390153 Neuroblastoma Cot 25-normalized .c 4321 to 5225 1 to 898       898/899
(99 %)
17 diff
(98.2 %id)
BG615502 embryonal carcinoma, testis .c 4357 to 5146 1 to 799       799/799
(100 %)
21 diff
(97.4 %id)
BU942175 mixed (pool of 40 RNAs) .c 4362 to 5080 1 to 725       725/726
(99 %)
11 diff
(98.5 %id)
BG494949 lung, mucoepidermoid carcinoma .c 4363 to 5021 1 to 659       659/659
(100 %)
6 diff
(99.1 %id)
CX783760 human embryonic stem cells .c 4499 to 5344 1 to 846       846/846
(100 %)
0 diff
(100 %id)
DA283148 corpus callosum .c 4550 to 5128 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BQ007967 Chondrosarcoma, Left Pelvis .c 4651 to 5350 716 to 17   AAA   700/700
(100 %)
0 diff
(100 %id)
BI092454 cervix .c 4706 to 5381 127 to 801       675/803
(84 %)
9 diff
(98.9 %id)
DA572327 whole embryo, mainly body .c 4720 to 5498 2 to 776   capped   775/855
(90 %)
13 diff
(98.5 %id)
CN351947 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4737 to 5286 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BU741622 eye, fetal eye .c 4765 to 5427 681 to 19   AAA   663/663
(100 %)
0 diff
(100 %id)
CN351946 embryonic stem cells, cell lines H1, H7, andH9 .c 4830 to 5583 1 to 754       754/754
(100 %)
1 diff
(99.9 %id)
DN912240   .c 4892 to 5431 541 to 2       540/541
(99 %)
0 diff
(100 %id)
AA450286   .c 5043 to 5424 1 to 382       382/382
(100 %)
1 diff
(99.8 %id)
BX349906 Neuroblastoma Cot 25-normalized .c 5080 to 5987 906 to 1       906/906
(100 %)
4 diff
(99.6 %id)
BG575342 breast, mammary adenocarcinoma, cell line .c 5163 to 5933 1 to 767       767/767
(100 %)
7 diff
(99.1 %id)
TI_149274715   .c 5176 to 5970 70 to 854     Submitted on the opposite strand 785/1061
(73 %)
26 diff
(97.6 %id)
BM784445 stomach .c 5178 to 5426 1 to 249   AAA   249/249
(100 %)
0 diff
(100 %id)
CB852894 Human Lung Epithelial cells, lung .c 5198 to 5434 11 to 247     Submitted on the opposite strand 237/263
(90 %)
3 diff
(98.9 %id)
AA593773 breast, breast tumor .c 5285 to 5705 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI659700 Prostate .c 5301 to 5797 497 to 1       497/497
(100 %)
0 diff
(100 %id)
AI376995   .c 5386 to 5861 489 to 14   AAA   476/476
(100 %)
0 diff
(100 %id)
CB963347 Blood vessels - aorta, basilar and artery .c 5510 to 6227 1 to 722       722/726
(99 %)
13 diff
(98.3 %id)
AA352559   .c 5514 to 5827 1 to 314       314/314
(100 %)
0 diff
(100 %id)
AA481034 germinal center B cell .c 5730 to 6190 1 to 462   fully sequenced, Submitted on the opposite strand 462/462
(100 %)
3 diff
(99.4 %id)
AA291147 germinal center B cell .c 5738 to 6135 1 to 396       396/396
(100 %)
1 diff
(99.8 %id)
AA281134 germinal center B cell .c 5738 to 6076 1 to 337       337/337
(100 %)
1 diff
(99.8 %id)
TI_154137007   .c 5944 to 6616 762 to 96   AAA   667/931
(71 %)
11 diff
(98.9 %id)
AW978659   .c 5947 to 6608 664 to 1     Submitted on the opposite strand 664/665
(99 %)
14 diff
(97.9 %id)
DN915447   .c 6018 to 6609 591 to 1       591/591
(100 %)
2 diff
(99.7 %id)
DB359326 whole embryo, mainly body .c 6076 to 6616 540 to 1       540/540
(100 %)
9 diff
(98.4 %id)
BE467292 carcinoid, lung .c 6100 to 6615 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AI767599 Kidney .c 6107 to 6617 511 to 1       511/511
(100 %)
0 diff
(100 %id)
BE463724 Kidney .c 6130 to 6618 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AI086083 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 6134 to 6616 495 to 13   AAA   483/483
(100 %)
0 diff
(100 %id)
AW470767 2 pooled tumors (clear cell type), Kidney .c 6140 to 6616 488 to 12   AAA   477/477
(100 %)
0 diff
(100 %id)
AA303204 aorta .c 6144 to 6379 1 to 236       236/236
(100 %)
0 diff
(100 %id)
AI431890 Kidney .c 6147 to 6616 486 to 17   AAA   470/470
(100 %)
0 diff
(100 %id)
AA481088 germinal center B cell .c 6160 to 6597 440 to 1   fully sequenced, Submitted on the opposite strand 440/440
(100 %)
3 diff
(99.4 %id)
AI374843   .c 6163 to 6620 460 to 3   tiling clone,   458/460
(99 %)
0 diff
(100 %id)
AA281054 germinal center B cell .c 6171 to 6611 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
AA291148 germinal center B cell .c 6176 to 6609 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AW612625 Kidney .c 6177 to 6616 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI932268 anaplastic oligodendroglioma, brain .c 6191 to 6616 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA458626 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 6198 to 6613 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AI167540 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 6214 to 6613 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AA450287   .c 6228 to 6616 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AI631854 Kidney .c 6397 to 6616 231 to 12   AAA   220/220
(100 %)
0 diff
(100 %id)
AA283238   .c 6522 to 6610 87 to 1       87/87
(100 %)
2 diff
(97.8 %id)
DA034263   .d 1 to 519 2 to 521   tiling clone, capped   520/520
(100 %)
1 diff
(99.9 %id)
DA862915 placenta .d 2 to 542 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
CD109659 Human Placenta, placenta .d 17 to 736 28 to 758       731/803
(91 %)
28 diff
(96.6 %id)
NM_006047.4   .d 17 to 6637 1 to 6621 exact RefSeq, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 6621/6621
(100 %)
0 diff
(100 %id)
DA665761   .d 18 to 503 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DB165644 thymus .d 18 to 588 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA222086 brain .d 27 to 500 2 to 475   capped   474/474
(100 %)
0 diff
(100 %id)
DA413305 thalamus .d 27 to 580 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA760097   .d 27 to 572 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA834616 placenta .d 27 to 565 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB080659 testis .d 27 to 503 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DB139796 thymus .d 27 to 542 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DB281650 uterus .d 27 to 565 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AL514548 neuroblastoma, placenta .d 28 to 1042 1 to 1002   AAA   1002/1034
(96 %)
18 diff
(98.3 %id)
BC012787 Placenta, choriocarcinoma .d 29 to 3579 1 to 3551 exact available from MGC, AAA   3551/3551
(100 %)
1 diff
(100.0 %id)
BC013981 Placenta, choriocarcinoma .d 29 to 3579 1 to 3551 exact available from MGC, AAA   3551/3551
(100 %)
1 diff
(100.0 %id)
DA028675   .d 30 to 599 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA244061 brain .d 30 to 598 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA408356 thalamus .d 30 to 519 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DB162185 thymus .d 30 to 631 2 to 603   capped   602/602
(100 %)
4 diff
(99.4 %id)
DA006894   .d 31 to 608 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA762709 tongue .d 31 to 621 2 to 592   capped   591/591
(100 %)
3 diff
(99.5 %id)
BJ996645 hepatoblastoma .d 32 to 521 1 to 490       490/490
(100 %)
0 diff
(100 %id)
CF593394 Human Placenta, placenta .d 32 to 717 30 to 722       693/867
(79 %)
20 diff
(97.7 %id)
DB220343 trachea .d 32 to 604 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA127696 cerebellum .d 33 to 621 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
DA323994 hippocampus .d 33 to 598 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA405821 thalamus .d 33 to 597 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA459817 tongue, tumor tissue .d 33 to 519 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
BP873022 embryonal kidney .d 33 to 615 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA585521 lung .d 33 to 612 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA754492   .d 33 to 478 2 to 447   capped   446/446
(100 %)
0 diff
(100 %id)
DA757002   .d 33 to 589 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA758583   .d 33 to 579 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA859585 placenta .d 33 to 578 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA889578   .d 33 to 592 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DB158264 thymus .d 33 to 635 2 to 604   capped   603/603
(100 %)
0 diff
(100 %id)
DB159435 thymus .d 33 to 614 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB162328 thymus .d 33 to 603 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB218324 trachea .d 33 to 481 2 to 450   capped   449/449
(100 %)
0 diff
(100 %id)
DB225802 trachea .d 33 to 596 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB237181 trachea .d 33 to 608 2 to 577   capped   576/577
(99 %)
2 diff
(99.7 %id)
DA034313   .d 34 to 503 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DA097805 cerebellum .d 34 to 542 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA103955 cerebellum .d 34 to 578 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA217767 brain .d 34 to 510 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DA234889 brain .d 34 to 610 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA307132 hippocampus .d 34 to 501 2 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DA322143 hippocampus .d 34 to 678 2 to 646   capped   645/645
(100 %)
0 diff
(100 %id)
DA322673 hippocampus .d 34 to 579 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA338583 hippocampus .d 34 to 632 2 to 601   capped   600/600
(100 %)
1 diff
(99.9 %id)
DA406164 thalamus .d 34 to 593 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA435488 tongue, tumor tissue .d 34 to 597 2 to 565   capped   564/565
(99 %)
1 diff
(99.9 %id)
DA451746 tongue, tumor tissue .d 34 to 608 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA456188 tongue, tumor tissue .d 34 to 503 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DA458154 tongue, tumor tissue .d 34 to 578 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA460536 tongue, tumor tissue .d 34 to 611 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA460701 tongue, tumor tissue .d 34 to 510 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DA462060 tongue, tumor tissue .d 34 to 608 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA500250 brain .d 34 to 606 2 to 575   capped   574/578
(99 %)
2 diff
(99.7 %id)
DA506657 brain .d 34 to 611 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA548723   .d 34 to 611 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA649587   .d 34 to 579 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA650114   .d 34 to 575 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA720282   .d 34 to 542 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA721070   .d 34 to 519 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA721945   .d 34 to 565 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA722389   .d 34 to 603 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA727202   .d 34 to 599 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA727203   .d 34 to 613 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA756423   .d 34 to 519 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA756480   .d 34 to 596 2 to 564   capped   563/564
(99 %)
1 diff
(99.9 %id)
DA760402   .d 34 to 588 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA776103 brain .d 34 to 598 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA800232 brain .d 34 to 598 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA802957 brain .d 34 to 590 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA806770 brain .d 34 to 600 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA808266 brain .d 34 to 608 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA819124   .d 34 to 542 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA862581 placenta .d 34 to 565 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA863292 placenta .d 34 to 674 2 to 642   capped   641/641
(100 %)
1 diff
(99.9 %id)
DA886508   .d 34 to 561 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA889776   .d 34 to 590 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA919368 small intestine .d 34 to 510 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DB067630 testis .d 34 to 587 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB075714 testis .d 34 to 631 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DB094414 testis .d 34 to 587 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB097707 testis .d 34 to 542 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DB098584 testis .d 34 to 620 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB216877 trachea .d 34 to 578 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB238395 trachea .d 34 to 542 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA348480 substantia nigra .d 36 to 616 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA888310   .d 36 to 588 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA532838 brain .d 37 to 600 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA720681   .d 37 to 589 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB230133 trachea .d 37 to 627 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DA741118   .d 38 to 503 2 to 467   capped   466/466
(100 %)
0 diff
(100 %id)
DA108542 cerebellum .d 39 to 601 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA332870 hippocampus .d 39 to 622 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA478880   .d 39 to 603 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA509841 brain .d 39 to 613 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB082086 testis .d 39 to 503 2 to 466   capped   465/465
(100 %)
0 diff
(100 %id)
DB228607 trachea .d 41 to 607 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
CN371884 embryonic stem cells, DMSO-treated H9 cellline .d 43 to 690 8 to 655       648/655
(98 %)
7 diff
(99.0 %id)
BU187232 eye, retinoblastoma .d 43 to 884 11 to 856       846/857
(98 %)
13 diff
(98.5 %id)
DN997975 breast cancer, Mammary gland (cancer tissue) .d 48 to 778 1 to 731       731/731
(100 %)
6 diff
(99.2 %id)
AF345332   .d 53 to 4145 1 to 4094 exact tiling clone,   4094/4097
(99 %)
2 diff
(100.0 %id)
CN371881 embryonic stem cells, cell lines H1, H7, andH9 .d 53 to 676 1 to 625       625/625
(100 %)
3 diff
(99.6 %id)
BU521697 leiomyosarcoma, uterus .d 53 to 908 1 to 864       864/866
(99 %)
17 diff
(98.1 %id)
CN371895 embryonic stem cells, cell lines H1, H7, andH9 .d 55 to 745 1 to 691       691/691
(100 %)
2 diff
(99.8 %id)
CN371871 embryonic stem cells, cell lines H1, H7, andH9 .d 165 to 954 3 to 790       792/790
(100 %)
6 diff
(99.3 %id)
BQ720094 sympathetic trunk .d 166 to 900 1 to 745       745/922
(80 %)
14 diff
(98.5 %id)
BU153061 embryonal carcinoma, cell line, testis .d 181 to 982 21 to 828       808/916
(88 %)
26 diff
(97.2 %id)
BY795345 eye .d 184 to 803 1 to 620       620/620
(100 %)
0 diff
(100 %id)
AL514547 neuroblastoma, placenta .d 2633 to 3580 941 to 1       941/962
(97 %)
32 diff
(96.7 %id)
AW964878   .e 1 to 587 1 to 588   tiling clone,   588/589
(99 %)
13 diff
(97.8 %id)
NM_003915.4   .e 1 to 2191 1 to 2191 exact RefSeq, AAA   2191/2191
(100 %)
0 diff
(100 %id)
BE707507 head_neck .e 198 to 637 440 to 1       440/440
(100 %)
0 diff
(100 %id)
BE931627 head_neck .e 198 to 637 440 to 1       440/440
(100 %)
0 diff
(100 %id)
U83246   .e 227 to 2191 1 to 1965 exact tiling clone, AAA   1965/1965
(100 %)
4 diff
(99.8 %id)
T35775 synovial membrane .e 268 to 559 1 to 293       293/293
(100 %)
1 diff
(99.7 %id)
AW958240   .e 269 to 847 1 to 577       577/577
(100 %)
18 diff
(96.9 %id)
NM_152929.1   .f 1 to 2077 1 to 2077 exact RefSeq, AAA   2077/2077
(100 %)
0 diff
(100 %id)
AW411495 muscle, rhabdomyosarcoma .f 41 to 690 16 to 665   tiling clone,   650/665
(97 %)
6 diff
(99.1 %id)
BF308316 muscle, rhabdomyosarcoma .f 45 to 791 1 to 739   tiling clone,   741/901
(82 %)
20 diff
(97.8 %id)
AW411496 muscle, rhabdomyosarcoma .f 1432 to 2077 683 to 38   tiling clone, AAA   646/646
(100 %)
3 diff
(99.6 %id)
NM_152927.1   .g 1 to 2061 1 to 2061 exact RefSeq, AAA   2061/2061
(100 %)
0 diff
(100 %id)
TI_44170613   .g 20 to 733 123 to 838       716/838
(85 %)
8 diff
(99.1 %id)
BG701713 brain, hippocampus .g 21 to 791 1 to 773   tiling clone,   773/841
(91 %)
8 diff
(99.1 %id)
BI552809 brain, hippocampus .g 21 to 733 1 to 715       715/715
(100 %)
6 diff
(99.2 %id)
BI668493 brain, hypothalamus .g 22 to 709 1 to 688       688/689
(99 %)
10 diff
(98.6 %id)
DB472381 hippocampus .g 27 to 512 1 to 486       486/486
(100 %)
0 diff
(100 %id)
DB477556 hippocampus .g 27 to 510 1 to 484       484/484
(100 %)
0 diff
(100 %id)
TI_44344664   .g 27 to 709 83 to 765       683/766
(89 %)
9 diff
(98.9 %id)
BI917584 brain .g 41 to 672 1 to 633       633/635
(99 %)
2 diff
(99.7 %id)
TI_57244807   .g 41 to 672 39 to 671       633/673
(94 %)
7 diff
(99.0 %id)
AI750467 Bone, Hip .g 53 to 293 1 to 240       240/240
(100 %)
7 diff
(97.1 %id)
TI_159677471   .g 54 to 972 43 to 958   tiling clone,   916/1091
(83 %)
7 diff
(99.4 %id)
CF132677 Chondrosarcoma Lung Metastasis cell lines, lung .g 55 to 830 1 to 776       776/776
(100 %)
0 diff
(100 %id)
NM_152928.1   .h 1 to 2029 1 to 2029 exact RefSeq, AAA   2029/2029
(100 %)
0 diff
(100 %id)
DB249050 uterus .h 27 to 502 2 to 477   tiling clone, capped   476/476
(100 %)
1 diff
(99.8 %id)
DA983782 synovial membrane tissue from rheumatioidarthritis .h 28 to 581 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BX397444 Placenta Cot 25-normalized .h 38 to 924 1 to 884   tiling clone,   884/975
(90 %)
12 diff
(98.8 %id)
CX873508 embryonic stem .h 41 to 892 1 to 852   tiling clone,   852/852
(100 %)
0 diff
(100 %id)
TI_57146010   .h 42 to 858 64 to 878       815/879
(92 %)
16 diff
(98.2 %id)
BI759187 pooled colon, kidney, stomach .h 45 to 858 1 to 812       812/813
(99 %)
10 diff
(98.8 %id)
BM547705 brain, hippocampus .h 53 to 675 1 to 630       630/1228
(51 %)
17 diff
(98.7 %id)
DN996969 breast cancer, Mammary gland (cancer tissue) .h 65 to 658 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
CD514737 White Matter .h 119 to 805 1 to 691       691/843
(81 %)
6 diff
(99.3 %id)
NM_152930.1   .i 1 to 2204 1 to 2204 exact RefSeq, AAA   2204/2204
(100 %)
0 diff
(100 %id)
DA490754 brain .i 21 to 524 2 to 504   tiling clone, capped   503/503
(100 %)
1 diff
(99.9 %id)
DA968384 stomach .i 24 to 579 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BM791778 stomach .i 26 to 674 9 to 657       649/649
(100 %)
0 diff
(100 %id)
DB475424 hippocampus .i 27 to 479 1 to 453       453/454
(99 %)
3 diff
(99.4 %id)
DA958206 Spleen .i 27 to 570 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB213509 trachea .i 28 to 392 2 to 366   capped   365/365
(100 %)
0 diff
(100 %id)
DB217588 trachea .i 28 to 394 2 to 368   capped   367/367
(100 %)
0 diff
(100 %id)
DB234038 trachea .i 33 to 377 2 to 346   capped   345/345
(100 %)
0 diff
(100 %id)
BG828670 muscle, rhabdomyosarcoma .i 38 to 560 1 to 538       533/1002
(53 %)
42 diff
(95.9 %id)
BG913841 anaplastic oligodendroglioma with 1p/19qloss, brain .i 40 to 861 1 to 823   tiling clone,   823/828
(99 %)
17 diff
(98.0 %id)
AI525640 Prostate .i 56 to 615 17 to 591       575/930
(61 %)
21 diff
(97.8 %id)
DN995325 breast cancer, Mammary gland (cancer tissue) .i 94 to 608 22 to 535       514/535
(96 %)
6 diff
(98.9 %id)
NM_152925.1   .j 1 to 1976 1 to 1976 exact RefSeq, AAA   1976/1976
(100 %)
0 diff
(100 %id)
BI600902 brain, hypothalamus .j 5 to 887 1 to 886   tiling clone,   884/901
(98 %)
37 diff
(95.9 %id)
TI_45214181   .j 7 to 887 151 to 1034       882/1049
(84 %)
38 diff
(96.4 %id)
BQ440897 eye, retinoblastoma .j 19 to 882 1 to 881       881/890
(98 %)
21 diff
(97.7 %id)
AW403566 lymph .j 20 to 410 1 to 391       391/391
(100 %)
5 diff
(98.8 %id)
DA135308 alzheimer cortex .j 21 to 560 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BI601718 brain, hypothalamus .j 22 to 850 1 to 834       834/834
(100 %)
15 diff
(98.3 %id)
BG699456 brain, hippocampus .j 23 to 834 1 to 815       815/815
(100 %)
14 diff
(98.3 %id)
BI460189 testis .j 23 to 733 1 to 710       710/710
(100 %)
8 diff
(98.9 %id)
TI_45214774   .j 27 to 850 154 to 982       829/982
(84 %)
17 diff
(98.3 %id)
DA947678 Spleen .j 27 to 589 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA092668 cerebellum .j 28 to 584 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA201446 brain .j 28 to 608 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
BU145800 ductal carcinoma, cell line, Pancreas .j 28 to 888 1 to 867       867/881
(98 %)
17 diff
(98.1 %id)
DA931182 Spleen .j 28 to 641 2 to 615   capped   614/614
(100 %)
0 diff
(100 %id)
DA961117 Spleen .j 28 to 579 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CX756221 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 29 to 738 1 to 710     Submitted on the opposite strand 710/711
(99 %)
1 diff
(99.9 %id)
BM017904 astrocytoma grade IV, cell line, brain .j 31 to 746 1 to 719       719/719
(100 %)
5 diff
(99.4 %id)
BQ015197 Chondrosarcoma, Left Pubic Bone .j 32 to 732 17 to 717     Submitted on the opposite strand 701/701
(100 %)
1 diff
(99.9 %id)
CX163954 human embryonic stem cells differentiated toan early endodermal cell type .j 32 to 814 1 to 783       783/783
(100 %)
4 diff
(99.5 %id)
TI_59388482   .j 32 to 746 100 to 817       718/718
(100 %)
4 diff
(99.5 %id)
DN991590 brain, whole brain .j 33 to 595 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
BG682960 brain, neuroblastoma, cell line .j 37 to 787 1 to 754       752/754
(99 %)
9 diff
(98.9 %id)
BX426300 B cells (Ramos cell line) .j 38 to 958 1 to 919       919/919
(100 %)
4 diff
(99.6 %id)
BF982913 duodenal adenocarcinoma, cell line, small intestine .j 38 to 653 4 to 619       616/619
(99 %)
5 diff
(99.2 %id)
BG422314 Kidney, renal cell adenocarcinoma .j 38 to 787 1 to 763       761/918
(82 %)
21 diff
(97.8 %id)
CN409827 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 39 to 709 12 to 682       671/682
(98 %)
6 diff
(99.2 %id)
BX337557 Placenta Cot 25-normalized .j 39 to 778 1 to 739       739/739
(100 %)
3 diff
(99.6 %id)
BI823503 pooled brain, lung, testis .j 39 to 646 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BQ227391 epithelioid carcinoma, Pancreas .j 39 to 795 1 to 764       764/850
(89 %)
8 diff
(99.1 %id)
CA489837   .j 39 to 932 1 to 900       900/903
(99 %)
10 diff
(98.9 %id)
CV810590 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 39 to 804 1 to 766       766/880
(87 %)
9 diff
(99.0 %id)
TI_57202682   .j 39 to 646 55 to 663       609/663
(91 %)
7 diff
(99.0 %id)
AI750480 Bone, Hip .j 39 to 541 9 to 510       504/510
(98 %)
5 diff
(99.1 %id)
CR999877 T-Lymphocytes .j 39 to 682 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
BX440430 brain, fetal brain .j 40 to 1083 1 to 1036       1036/1074
(96 %)
15 diff
(98.7 %id)
BU146477 brain, neuroblastoma, cell line .j 40 to 880 1 to 843       843/908
(92 %)
7 diff
(99.3 %id)
BQ069203 brain, neuroblastoma, cell line .j 42 to 915 19 to 895       877/1022
(85 %)
21 diff
(98.0 %id)
BU179006 eye, retinoblastoma .j 42 to 875 1 to 850       845/870
(97 %)
27 diff
(96.9 %id)
TI_44459331   .j 42 to 751 61 to 769       709/769
(92 %)
7 diff
(99.1 %id)
BM011300 brain, neuroblastoma, cell line .j 43 to 648 1 to 607       607/607
(100 %)
2 diff
(99.7 %id)
BI871028 adenocarcinoma, cell line, Liver .j 44 to 887 1 to 850       850/865
(98 %)
22 diff
(97.5 %id)
BM909703 astrocytoma grade IV, cell line, brain .j 44 to 955 1 to 927       923/1073
(86 %)
14 diff
(98.7 %id)
TI_59380458   .j 44 to 648 57 to 662       606/606
(100 %)
1 diff
(99.9 %id)
BF528622 anaplastic oligodendroglioma with 1p/19qloss, brain .j 45 to 792 1 to 744       744/927
(80 %)
25 diff
(97.4 %id)
BG482452 choriocarcinoma, placenta .j 45 to 804 1 to 765       765/860
(88 %)
24 diff
(97.3 %id)
BG683375 brain, neuroblastoma, cell line .j 45 to 832 1 to 790       790/791
(99 %)
6 diff
(99.3 %id)
BI115064 muscle, rhabdomyosarcoma .j 45 to 682 1 to 638       638/638
(100 %)
5 diff
(99.3 %id)
BI223306 cervical carcinoma cell line, cervix .j 45 to 834 1 to 791       791/791
(100 %)
2 diff
(99.8 %id)
BI518869 leukocyte .j 45 to 751 1 to 706       706/706
(100 %)
1 diff
(99.9 %id)
CT004955 T-Lymphocytes .j 45 to 652 1 to 608       608/608
(100 %)
0 diff
(100 %id)
CR978588 T-Lymphocytes .j 45 to 449 1 to 405       405/411
(98 %)
1 diff
(99.8 %id)
BF206934 brain, neuroblastoma .j 46 to 678 1 to 632       632/635
(99 %)
5 diff
(99.3 %id)
BG758893 B-cells, primary B-cells from tonsils (cell line) .j 46 to 885 1 to 841       841/940
(89 %)
24 diff
(97.5 %id)
BM475581 embryonal carcinoma, cell line, testis .j 46 to 980 1 to 944       944/1065
(88 %)
24 diff
(97.8 %id)
CX758670 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 46 to 784 1 to 736     Submitted on the opposite strand 736/759
(96 %)
8 diff
(99.0 %id)
CN409820 embryonic stem cells, cell lines H1, H7, andH9 .j 47 to 594 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
AW248320.
matches multiple genes
lung, small cell carcinoma .j 48 to 592 9 to 553     also hits gene CDKAL1 545/553
(98 %)
1 diff
(99.9 %id)
AW245816.
matches multiple genes
lung, small cell carcinoma .j 48 to 593 9 to 554     also hits gene CDKAL1 546/554
(98 %)
3 diff
(99.5 %id)
BG323772 Kidney, renal cell adenocarcinoma .j 48 to 887 1 to 841       841/863
(97 %)
13 diff
(98.5 %id)
CN409818 embryonic stem cells, cell lines H1, H7, andH9 .j 49 to 782 1 to 734       734/734
(100 %)
1 diff
(99.9 %id)
BM477885 leiomyosarcoma, uterus .j 49 to 798 1 to 749       749/1008
(74 %)
20 diff
(98.1 %id)
DR006790 Spleen .j 49 to 730 1 to 685       685/687
(99 %)
12 diff
(98.3 %id)
BX363577   .j 50 to 977 1 to 926   fully sequenced,   926/926
(100 %)
2 diff
(99.8 %id)
BX406197 fetal liver, Liver .j 50 to 970 1 to 909       909/912
(99 %)
13 diff
(98.6 %id)
BQ061582 lymph, lymphoma, cell line .j 50 to 882 1 to 836       836/1061
(78 %)
32 diff
(97.0 %id)
BQ055482 lymph, lymphoma, cell line .j 52 to 880 1 to 831       831/994
(83 %)
13 diff
(98.7 %id)
BQ056433 lymph, lymphoma, cell line .j 52 to 751 1 to 701       701/1024
(68 %)
11 diff
(99.0 %id)
BQ056460 lymph, lymphoma, cell line .j 52 to 980 1 to 935       935/1016
(92 %)
23 diff
(97.8 %id)
BQ057390 lymph, lymphoma, cell line .j 52 to 706 1 to 658       658/1319
(49 %)
8 diff
(99.4 %id)
BQ057895 lymph, lymphoma, cell line .j 52 to 970 1 to 924       924/1053
(87 %)
19 diff
(98.2 %id)
BQ058879 lymph, lymphoma, cell line .j 52 to 864 1 to 822       822/988
(83 %)
15 diff
(98.5 %id)
BQ059318 lymph, lymphoma, cell line .j 52 to 974 1 to 927       927/1029
(90 %)
8 diff
(99.3 %id)
BQ059469 lymph, lymphoma, cell line .j 52 to 970 1 to 926       926/1045
(88 %)
15 diff
(98.6 %id)
BQ059563 lymph, lymphoma, cell line .j 52 to 788 1 to 744       744/1100
(67 %)
17 diff
(98.5 %id)
BQ060006 lymph, lymphoma, cell line .j 52 to 951 1 to 912       912/960
(95 %)
13 diff
(98.7 %id)
BQ064910 lymph, lymphoma, cell line .j 52 to 964 1 to 928       926/994
(93 %)
20 diff
(98.0 %id)
BQ643443 lymph, lymphoma, cell line .j 52 to 864 1 to 825       825/885
(93 %)
20 diff
(97.8 %id)
BQ642062 lymph, lymphoma, cell line .j 52 to 788 1 to 740   AAA   740/951
(77 %)
11 diff
(98.9 %id)
BQ643187 lymph, lymphoma, cell line .j 52 to 880 1 to 848       848/950
(89 %)
12 diff
(98.8 %id)
BQ642625 lymph, lymphoma, cell line .j 52 to 958 1 to 915       913/916
(99 %)
21 diff
(97.8 %id)
BQ642650 lymph, lymphoma, cell line .j 52 to 882 1 to 834       834/927
(89 %)
11 diff
(98.9 %id)
BX446023 placenta .j 53 to 756 1 to 708       708/841
(84 %)
27 diff
(96.8 %id)
AL515420 neuroblastoma, placenta .j 53 to 1122 1 to 1066       1066/1086
(98 %)
16 diff
(98.6 %id)
BX446028 neuroblastoma .j 53 to 868 1 to 812       812/812
(100 %)
8 diff
(99.1 %id)
BX447005 neuroblastoma .j 53 to 968 1 to 914       914/914
(100 %)
8 diff
(99.2 %id)
CR624410 neuroblastoma .j 53 to 1978 1 to 1926 exact tiling clone,   1926/1926
(100 %)
0 diff
(100 %id)
BX403282 Neuroblastoma Cot 10-normalized .j 53 to 882 1 to 834       834/841
(99 %)
11 diff
(98.7 %id)
BE410267 choriocarcinoma, placenta .j 53 to 706 1 to 655       655/693
(94 %)
5 diff
(99.3 %id)
BM547832 brain, hippocampus .j 54 to 880 1 to 832       832/1139
(73 %)
12 diff
(99.0 %id)
DR007135 Spleen .j 54 to 765 7 to 719       713/719
(99 %)
2 diff
(99.8 %id)
BU145243 ductal carcinoma, cell line, Pancreas .j 56 to 880 1 to 830       830/894
(92 %)
7 diff
(99.3 %id)
BQ689162 ductal carcinoma, cell line, Pancreas .j 56 to 684 1 to 635       635/1000
(63 %)
14 diff
(98.6 %id)
BQ691553 ductal carcinoma, cell line, Pancreas .j 56 to 903 1 to 855       851/855
(99 %)
13 diff
(98.5 %id)
BU849161 ovary, teratocarcinoma, cell line .j 56 to 927 1 to 884       882/889
(99 %)
17 diff
(98.1 %id)
CN409813 embryonic stem cells, DMSO-treated H9 cellline .j 59 to 631 1 to 573       573/573
(100 %)
5 diff
(99.2 %id)
BU174346 ductal carcinoma, cell line, Pancreas .j 61 to 779 1 to 737   AAA   735/924
(79 %)
29 diff
(96.9 %id)
BU163174 ductal carcinoma, cell line, Pancreas .j 61 to 880 1 to 822       822/964
(85 %)
6 diff
(99.4 %id)
BQ688053 ductal carcinoma, cell line, Pancreas .j 61 to 936 1 to 880       880/880
(100 %)
8 diff
(99.1 %id)
BE315417 adenocarcinoma cell line, ovary .j 65 to 693 1 to 627       627/629
(99 %)
9 diff
(98.6 %id)
BE731247 choriocarcinoma, placenta .j 65 to 887 1 to 821       821/925
(88 %)
16 diff
(98.3 %id)
BE797425 lung, small cell carcinoma .j 65 to 784 1 to 721       721/1121
(64 %)
8 diff
(99.3 %id)
BE869407 adenocarcinoma, colon .j 66 to 584 1 to 520       520/520
(100 %)
6 diff
(98.9 %id)
CN409825 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 68 to 804 1 to 738       738/738
(100 %)
10 diff
(98.7 %id)
BE389823 endometrium, adenocarcinoma cell line, uterus .j 68 to 565 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BE391286 endometrium, adenocarcinoma cell line, uterus .j 68 to 633 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BF303974 muscle, rhabdomyosarcoma .j 69 to 781 1 to 707       706/950
(74 %)
16 diff
(98.4 %id)
BE741426 adenocarcinoma cell line, ovary .j 77 to 851 1 to 773       773/775
(99 %)
9 diff
(98.9 %id)
BM005920 hepatocellular carcinoma, cell line, Liver .j 81 to 636 1 to 556       556/558
(99 %)
3 diff
(99.5 %id)
BQ653368 hepatocellular carcinoma, cell line, Liver .j 83 to 788 1 to 707       707/980
(72 %)
8 diff
(99.2 %id)
BG760429 melanotic melanoma, high MDR (cell line), skin .j 91 to 916 1 to 823       823/832
(98 %)
9 diff
(99.0 %id)
BG766395 melanotic melanoma, high MDR (cell line), skin .j 91 to 849 1 to 763       763/763
(100 %)
4 diff
(99.5 %id)
CT002163 T-Lymphocytes .j 99 to 875 1 to 778       778/779
(99 %)
5 diff
(99.4 %id)
BU180165 ductal carcinoma, cell line, Pancreas .j 144 to 880 23 to 759       737/865
(85 %)
5 diff
(99.5 %id)
BQ688670 ductal carcinoma, cell line, Pancreas .j 145 to 1025 1 to 891       891/923
(96 %)
24 diff
(97.4 %id)
BG341093 B-cells, primary B-cells from tonsils (cell line) .j 153 to 887 2 to 737       736/909
(80 %)
13 diff
(98.6 %id)
BG342091 B-cells, primary B-cells from tonsils (cell line) .j 153 to 882 2 to 728       727/800
(90 %)
13 diff
(98.4 %id)
BX363576   .j 960 to 1940 981 to 1   fully sequenced,   981/981
(100 %)
2 diff
(99.8 %id)
BX426299 B cells (Ramos cell line) .j 979 to 1952 970 to 1       970/972
(99 %)
19 diff
(98.1 %id)
BX448605 fetal liver, Liver .j 1026 to 1935 912 to 7       906/965
(93 %)
11 diff
(98.9 %id)
BU527562 epidermoid carcinoma, cell line, lung .j 1088 to 1976 938 to 46   AAA Submitted on the opposite strand 893/895
(99 %)
25 diff
(97.3 %id)
BE870594 adenocarcinoma, colon .j 1101 to 1818 1 to 714       714/715
(99 %)
8 diff
(98.9 %id)
BQ072735 leukocyte .j 1112 to 1974 20 to 881       862/1053
(81 %)
25 diff
(97.7 %id)
BX337556 Placenta Cot 25-normalized .j 1124 to 1949 825 to 1       825/825
(100 %)
4 diff
(99.6 %id)
BE731406 choriocarcinoma, placenta .j 1135 to 1966 1 to 840       836/844
(99 %)
29 diff
(96.6 %id)
BG574122 breast, mammary adenocarcinoma, cell line .j 1143 to 1845 1 to 702       702/703
(99 %)
2 diff
(99.8 %id)
BE736469 adenocarcinoma, Pancreas .j 1151 to 1891 1 to 734       734/961
(76 %)
18 diff
(98.2 %id)
AL515419 neuroblastoma, placenta .j 1153 to 1978 824 to 1       824/945
(87 %)
24 diff
(97.5 %id)
BG032844 breast, mammary adenocarcinoma, cell line .j 1155 to 1937 1 to 779       779/936
(83 %)
18 diff
(98.1 %id)
BU500667   .j 1155 to 1974 12 to 847       836/969
(86 %)
31 diff
(96.9 %id)
TI_149303634   .j 1159 to 1979 896 to 84   AAA   813/972
(83 %)
15 diff
(98.5 %id)
AF314092   .j 1183 to 1978 24 to 819       796/823
(96 %)
8 diff
(99.1 %id)
AA251402 germinal center B cell .j 1191 to 1582 1 to 389   fully sequenced,   389/389
(100 %)
4 diff
(99.0 %id)
BM916446 amelanotic melanoma, cell line, skin .j 1252 to 1976 1 to 735   AAA   731/735
(99 %)
8 diff
(99.0 %id)
BM564427 blood, natural killer cells, cell line .j 1257 to 1976 764 to 37   AAA Submitted on the opposite strand 728/1186
(61 %)
17 diff
(98.6 %id)
TI_149288612   .j 1259 to 1976 798 to 84   AAA   715/717
(99 %)
6 diff
(99.2 %id)
TI_149296626   .j 1259 to 1976 790 to 80   AAA   711/925
(76 %)
9 diff
(99.1 %id)
CA423032 cell lines, Chondrosarcoma .j 1263 to 1990 746 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 728/728
(100 %)
0 diff
(100 %id)
BU621630 cell lines, Chondrosarcoma .j 1264 to 1976 731 to 19   AAA   713/713
(100 %)
0 diff
(100 %id)
BG683974 brain, neuroblastoma, cell line .j 1265 to 1930 677 to 2       676/869
(77 %)
12 diff
(98.7 %id)
TI_154127006   .j 1265 to 1976 783 to 81   AAA   703/735
(95 %)
12 diff
(98.4 %id)
BI255249 cervical carcinoma cell line, cervix .j 1277 to 1847 1 to 572       572/573
(99 %)
3 diff
(99.5 %id)
TI_154053151   .j 1285 to 1976 770 to 84   AAA   687/897
(76 %)
9 diff
(99.0 %id)
CB851070 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1309 to 1979 685 to 16   AAA   670/670
(100 %)
2 diff
(99.8 %id)
TI_154132222   .j 1325 to 1976 759 to 106   AAA   654/779
(83 %)
12 diff
(98.5 %id)
AA152189 uterus .j 1327 to 1613 1 to 287   fully sequenced,   287/287
(100 %)
2 diff
(99.4 %id)
BU633930 cell lines, Chondrosarcoma .j 1332 to 1976 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
BE677704 dorsal root ganglia .j 1338 to 1977 640 to 1       640/640
(100 %)
8 diff
(98.8 %id)
BG036478 adenocarcinoma, cell line, Prostate .j 1338 to 1976 1 to 635   AAA   635/635
(100 %)
5 diff
(99.3 %id)
BM969171 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1341 to 1976 654 to 19   AAA   636/636
(100 %)
0 diff
(100 %id)
CA437080 lung, Metastatic Chondrosarcoma .j 1341 to 1976 653 to 19   AAA   635/635
(100 %)
1 diff
(99.9 %id)
CA309947 Alveolar Macrophage, lung .j 1341 to 1976 654 to 19   AAA   636/636
(100 %)
2 diff
(99.7 %id)
BU624786 cell lines, Enchondroma .j 1352 to 1976 642 to 19   AAA   624/632
(98 %)
7 diff
(98.9 %id)
AI612784 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 1354 to 1976 621 to 1       621/622
(99 %)
6 diff
(99.1 %id)
AI538159 Kidney .j 1355 to 1976 622 to 1       622/627
(99 %)
1 diff
(99.9 %id)
CA415904 Chondrosarcoma Cell line .j 1357 to 1976 633 to 16   AAA   618/618
(100 %)
4 diff
(99.4 %id)
BX376786 Neuroblastoma Cot 50-normalized .j 1360 to 1978 1 to 619       619/619
(100 %)
5 diff
(99.2 %id)
AI052540   .j 1375 to 1976 613 to 11   AAA   603/604
(99 %)
5 diff
(99.2 %id)
BM511690 insulinoma, Pancreas .j 1377 to 1976 615 to 16   AAA   600/600
(100 %)
0 diff
(100 %id)
BI254562 cervical carcinoma cell line, cervix .j 1402 to 1976 1 to 577   AAA   573/577
(99 %)
5 diff
(99.2 %id)
BQ776024 Bone, Human Chondrosarcoma Cell Line .j 1408 to 1976 587 to 19   AAA   569/569
(100 %)
0 diff
(100 %id)
TI_149309422   .j 1410 to 1976 654 to 88   AAA   567/968
(58 %)
0 diff
(100 %id)
BU687820 lung .j 1410 to 1976 585 to 19   AAA   567/575
(98 %)
0 diff
(100 %id)
CA415458 Chondrosarcoma Grade II, Left Pelvis .j 1410 to 1976 585 to 19   AAA   567/567
(100 %)
0 diff
(100 %id)
BQ773276 Chondrosarcoma Cell line .j 1411 to 1976 583 to 19   AAA   565/565
(100 %)
1 diff
(99.9 %id)
BU631148 cell lines, Chondrosarcoma .j 1411 to 1976 584 to 19   AAA   566/566
(100 %)
5 diff
(99.2 %id)
CA307682 Alveolar Macrophage, lung .j 1411 to 1976 584 to 19   AAA   566/566
(100 %)
3 diff
(99.5 %id)
AI688277 colon .j 1422 to 1976 555 to 1       555/555
(100 %)
2 diff
(99.7 %id)
BG231745 blood, lymphocyte .j 1437 to 1991 556 to 2       555/556
(99 %)
1 diff
(99.9 %id)
BQ941347 sciatic nerve .j 1439 to 1991 1 to 553   tiling clone,   553/1037
(53 %)
2 diff
(99.9 %id)
AI457877 carcinoid, lung .j 1444 to 1977 534 to 1       534/535
(99 %)
3 diff
(99.5 %id)
BP390590 pancreatic islet .j 1453 to 1976 1 to 524     Submitted on the opposite strand 524/524
(100 %)
0 diff
(100 %id)
AI809162 B-cell, chronic lymphotic leukemia .j 1455 to 1976 533 to 12   AAA   522/522
(100 %)
4 diff
(99.3 %id)
AA858054 epithelium (cell line), Prostate .j 1464 to 1988 523 to 1       523/523
(100 %)
5 diff
(99.1 %id)
BP393063 pancreatic islet .j 1465 to 1976 1 to 512     Submitted on the opposite strand 512/512
(100 %)
1 diff
(99.9 %id)
AW574779 lymph .j 1469 to 1976 525 to 18   AAA   508/508
(100 %)
2 diff
(99.7 %id)
AI758318 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j 1485 to 1990 505 to 1       505/505
(100 %)
3 diff
(99.5 %id)
BI712856 Pancreas, Purified pancreatic islet .j 1488 to 1974 1 to 487   fully sequenced,   487/487
(100 %)
0 diff
(100 %id)
DB574757 hypothalamus .j 1497 to 1976 1 to 480     Submitted on the opposite strand 480/480
(100 %)
0 diff
(100 %id)
AI494515 anaplastic oligodendroglioma, brain .j 1509 to 1976 468 to 1       468/468
(100 %)
0 diff
(100 %id)
DB541138 hippocampus .j 1514 to 1976 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AI655444 pooled germ cell tumors .j 1520 to 1976 457 to 1       457/457
(100 %)
0 diff
(100 %id)
CB048145 Prostate .j 1527 to 1976 14 to 463   fully sequenced, AAA   450/463
(97 %)
6 diff
(98.8 %id)
AI651839 pooled germ cell tumors .j 1534 to 1977 444 to 1       444/444
(100 %)
0 diff
(100 %id)
BE388206 endometrium, adenocarcinoma cell line, uterus .j 1544 to 1976 1 to 433   AAA   433/433
(100 %)
0 diff
(100 %id)
BM927761 hepatocellular carcinoma, cell line, Liver .j 1544 to 1979 1 to 436   AAA   436/436
(100 %)
0 diff
(100 %id)
CA941013 Pancreas, Purified pancreatic islet .j 1546 to 1956 1 to 411   fully sequenced,   411/411
(100 %)
0 diff
(100 %id)
AA251334 germinal center B cell .j 1552 to 1977 425 to 1   fully sequenced,   425/425
(100 %)
3 diff
(99.3 %id)
AA150138 uterus .j 1583 to 1976 393 to 1   fully sequenced,   393/393
(100 %)
4 diff
(99.0 %id)
CA434095 Bone, Subchondral Bone .j 1601 to 1976 394 to 19   AAA   376/376
(100 %)
0 diff
(100 %id)
BI791446 Pancreas, Purified pancreatic islet .j 1604 to 1978 375 to 1   fully sequenced,   375/375
(100 %)
0 diff
(100 %id)
CA866036 Pancreas, Purified pancreatic islet .j 1610 to 1978 369 to 1   fully sequenced,   369/369
(100 %)
0 diff
(100 %id)
BG179864 adenocarcinoma, cell line, Prostate .j 1628 to 1976 1 to 349   AAA   349/349
(100 %)
0 diff
(100 %id)
DB332388 Spleen .j 1635 to 1976 342 to 1       342/347
(98 %)
7 diff
(98.0 %id)
CN409829 embryonic stem cells, cell lines H1, H7, andH9 .j 1775 to 1932 1 to 158       158/158
(100 %)
0 diff
(100 %id)
CB048144 Prostate .j 1794 to 1976 235 to 53   fully sequenced, AAA   183/183
(100 %)
0 diff
(100 %id)
AW515172 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 1826 to 1977 152 to 1       152/152
(100 %)
0 diff
(100 %id)
AA593842 colon, colon tumor .j 1831 to 1975 145 to 1       145/145
(100 %)
0 diff
(100 %id)
BE888517 leiomyosarcoma, uterus .j 1839 to 1971 1 to 133       133/133
(100 %)
0 diff
(100 %id)
AI383777 B-cell, chronic lymphotic leukemia .j 1851 to 1977 127 to 1       127/127
(100 %)
0 diff
(100 %id)
BM755522 Ascites, stomach .k 1 to 302 2 to 301   tiling clone,   301/301
(100 %)
2 diff
(99.4 %id)
BI825962 brain, medulla .k 30 to 812 1 to 783       783/783
(100 %)
0 diff
(100 %id)
TI_57173805   .k 30 to 812 28 to 810       783/810
(96 %)
6 diff
(99.3 %id)
NM_152926.1   .k 30 to 1963 1 to 1934 exact RefSeq, AAA   1934/1934
(100 %)
0 diff
(100 %id)
BU855860 ovary, teratocarcinoma, cell line .k 41 to 977 1 to 944   tiling clone,   944/944
(100 %)
7 diff
(99.3 %id)
CA454476   .k 48 to 867 1 to 821       821/898
(91 %)
12 diff
(98.7 %id)
DA578847   .k 50 to 603 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CB990581 Human Placenta, placenta .k 52 to 776 28 to 754       727/754
(96 %)
10 diff
(98.7 %id)
CD109601 Human Placenta, placenta .k 52 to 689 28 to 668       641/771
(83 %)
14 diff
(98.2 %id)
CN409822 embryonic stem cells, DMSO-treated H9 cellline .k 53 to 769 2 to 719       718/719
(99 %)
7 diff
(99.1 %id)
DA630120 Kidney .k 53 to 632 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BM149206 leukopheresis .k 55 to 273 1 to 219       219/260
(84 %)
12 diff
(95.4 %id)
DB481352 hippocampus .k 56 to 493 1 to 438       438/438
(100 %)
0 diff
(100 %id)
DA986195 synovial membrane tissue from rheumatioidarthritis .k 56 to 619 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
CR596654 Placenta Cot 25-normalized .k 57 to 1934 1 to 1878 exact     1878/1878
(100 %)
0 diff
(100 %id)
BX361232 Placenta Cot 25-normalized .k 57 to 1000 1 to 942   fully sequenced,   942/942
(100 %)
1 diff
(99.9 %id)
DA562310 heart .k 57 to 629 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CF141409 CNCAP(3)T-225 cell line, Prostate .k 57 to 490 44 to 477       434/477
(90 %)
6 diff
(98.8 %id)
CB159323 Liver .k 57 to 548 8 to 499       492/499
(98 %)
6 diff
(98.8 %id)
TI_154172115   .k 57 to 690 126 to 759       634/1084
(58 %)
25 diff
(97.7 %id)
CN409819 embryonic stem cells, DMSO-treated H9 cellline .k 58 to 651 1 to 594       594/594
(100 %)
0 diff
(100 %id)
AU280505   .k 58 to 624 1 to 567       567/567
(100 %)
0 diff
(100 %id)
CV816224 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .k 59 to 851 1 to 798       796/895
(88 %)
11 diff
(98.8 %id)
T35777 synovial membrane .k 61 to 346 1 to 288       288/288
(100 %)
2 diff
(99.4 %id)
BE045345 carcinoid, lung .k 62 to 517 1 to 456     Submitted on the opposite strand 456/456
(100 %)
0 diff
(100 %id)
CN409831 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 65 to 721 1 to 658       658/658
(100 %)
5 diff
(99.3 %id)
BQ637726 eye, retina .k 66 to 689 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
BF975243 B-cells, primary B-cells from tonsils (cell line) .k 66 to 852 1 to 794       794/909
(87 %)
22 diff
(97.6 %id)
BG469554 adenocarcinoma cell line, colon .k 66 to 727 1 to 661       661/948
(69 %)
6 diff
(99.4 %id)
BG759449 B-cells, primary B-cells from tonsils (cell line) .k 66 to 780 1 to 716       716/716
(100 %)
4 diff
(99.5 %id)
BG758158 B-cells, primary B-cells from tonsils (cell line) .k 66 to 771 1 to 708       708/1150
(61 %)
13 diff
(98.9 %id)
BG827456 muscle, rhabdomyosarcoma .k 66 to 709 1 to 667       622/667
(93 %)
23 diff
(96.6 %id)
BG831114 epithelioid carcinoma cell line, Pancreas .k 66 to 532 1 to 467       467/467
(100 %)
0 diff
(100 %id)
AL518566 brain, neuroblastoma, neuroblastoma cells .k 67 to 760 1 to 694       694/694
(100 %)
8 diff
(98.9 %id)
BG180008 adenocarcinoma, cell line, Prostate .k 67 to 774 1 to 703       703/949
(74 %)
19 diff
(98.0 %id)
BI770811 pooled lung and spleen .k 67 to 763 1 to 713       710/903
(78 %)
31 diff
(96.6 %id)
BQ068820 brain, neuroblastoma, cell line .k 67 to 938 1 to 878       878/948
(92 %)
10 diff
(99.0 %id)
TI_57184175   .k 67 to 763 28 to 740   AAA   710/918
(77 %)
33 diff
(96.5 %id)
BE300432 muscle, rhabdomyosarcoma .k 68 to 872 9 to 848   AAA   690/921
(74 %)
45 diff
(95.2 %id)
BG163503 hypernephroma, cell line, Kidney .k 68 to 782 1 to 716       716/803
(89 %)
17 diff
(97.9 %id)
BI335204 cervical carcinoma cell line, cervix .k 68 to 874 1 to 811       811/827
(98 %)
13 diff
(98.5 %id)
CA454637   .k 68 to 552 1 to 485       485/509
(95 %)
14 diff
(97.3 %id)
DN997373 breast cancer, Mammary gland (cancer tissue) .k 68 to 731 7 to 670       664/670
(99 %)
6 diff
(99.2 %id)
BG324413 Kidney, renal cell adenocarcinoma .k 69 to 700 1 to 632       632/901
(70 %)
16 diff
(98.3 %id)
BM923715 pooled colon, kidney, stomach .k 70 to 961 14 to 906       893/1022
(87 %)
17 diff
(98.4 %id)
BM923297 pooled colon, kidney, stomach .k 71 to 896 11 to 839       829/1122
(73 %)
15 diff
(98.7 %id)
CV808220 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .k 71 to 867 1 to 798       798/899
(88 %)
6 diff
(99.4 %id)
CV800829 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .k 71 to 781 1 to 703       703/849
(82 %)
9 diff
(99.0 %id)
DN993324 brain, whole brain .k 71 to 754 1 to 684       684/684
(100 %)
4 diff
(99.5 %id)
BG333753 melanotic melanoma, skin .k 72 to 699 1 to 629       629/929
(67 %)
12 diff
(98.8 %id)
BG473596 eye, retinoblastoma .k 72 to 632 1 to 568       566/568
(99 %)
20 diff
(96.5 %id)
BI089363 cervix .k 72 to 780 1 to 723       723/724
(99 %)
25 diff
(96.6 %id)
BG115160 duodenal adenocarcinoma, cell line, small intestine .k 73 to 638 1 to 570       570/1225
(46 %)
7 diff
(99.5 %id)
BI918687 brain .k 73 to 662 1 to 589       589/589
(100 %)
2 diff
(99.7 %id)
TI_57241035   .k 73 to 662 1 to 589       589/589
(100 %)
2 diff
(99.7 %id)
TI_59380783   .k 73 to 766 108 to 800       693/693
(100 %)
1 diff
(99.9 %id)
AA481899 ovarian tumor, ovary .k 74 to 530 1 to 455       455/456
(99 %)
4 diff
(99.2 %id)
BG025673 lymph, lymphoma, cell line .k 74 to 619 14 to 559       546/559
(97 %)
6 diff
(99.0 %id)
BG469996 adenocarcinoma cell line, colon .k 74 to 946 1 to 878       875/986
(88 %)
31 diff
(96.9 %id)
BG824720 adenocarcinoma cell line, colon .k 74 to 807 1 to 735       735/735
(100 %)
2 diff
(99.8 %id)
TI_57152692   .k 74 to 866 94 to 887       794/888
(89 %)
15 diff
(98.4 %id)
CT000058 T-Lymphocytes .k 74 to 676 1 to 603       603/610
(98 %)
1 diff
(99.9 %id)
BG251036 adenocarcinoma, cell line, Liver .k 75 to 773 1 to 700       700/1168
(59 %)
17 diff
(98.6 %id)
BM011612 brain, neuroblastoma, cell line .k 75 to 766 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
CX752662 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .k 75 to 785 1 to 711     Submitted on the opposite strand 711/711
(100 %)
0 diff
(100 %id)
CN409814 embryonic stem cells, DMSO-treated H9 cellline .k 76 to 730 1 to 657       657/657
(100 %)
3 diff
(99.6 %id)
BX421397 B cells (Ramos cell line) .k 76 to 1104 1 to 1021   fully sequenced,   1021/1021
(100 %)
21 diff
(98.0 %id)
BE892347 melanotic melanoma, skin .k 76 to 838 1 to 766       770/801
(96 %)
30 diff
(96.3 %id)
BM006048 hepatocellular carcinoma, cell line, Liver .k 76 to 868 1 to 798       798/844
(94 %)
11 diff
(98.7 %id)
BM917393 blood, natural killer cells, cell line .k 76 to 867 1 to 796       796/1107
(71 %)
17 diff
(98.5 %id)
BQ214434 melanotic melanoma, skin .k 76 to 961 1 to 893       891/912
(97 %)
11 diff
(98.8 %id)
BU507217 leiomyosarcoma, uterus .k 76 to 692 1 to 622       622/866
(71 %)
22 diff
(97.5 %id)
BX462386 B cells (Ramos cell line) .k 77 to 986 1 to 910       910/910
(100 %)
5 diff
(99.5 %id)
BM008859 adenocarcinoma, Pancreas .k 77 to 768 1 to 703       703/862
(81 %)
25 diff
(97.1 %id)
BM928474 hepatocellular carcinoma, cell line, Liver .k 77 to 1016 20 to 968       949/1035
(91 %)
28 diff
(97.3 %id)
TI_59386001   .k 77 to 868 62 to 858   AAA   797/834
(95 %)
10 diff
(98.9 %id)
TI_59386577   .k 77 to 768 60 to 762   AAA   703/852
(82 %)
25 diff
(97.1 %id)
BI764586 pooled colon, kidney, stomach .k 78 to 866 1 to 790       790/791
(99 %)
7 diff
(99.2 %id)
BM471983 melanotic melanoma, skin .k 78 to 766 1 to 702       700/946
(73 %)
24 diff
(97.5 %id)
BQ064570 lymph, lymphoma, cell line .k 78 to 966 1 to 897       897/964
(93 %)
20 diff
(98.0 %id)
BQ229445 embryonal carcinoma, cell line, testis .k 78 to 784 34 to 758       723/957
(75 %)
36 diff
(96.3 %id)
BQ650120 hepatocellular carcinoma, cell line, Liver .k 78 to 677 1 to 608       608/1102
(55 %)
15 diff
(98.7 %id)
BQ653834 hepatocellular carcinoma, cell line, Liver .k 78 to 620 1 to 543       543/1040
(52 %)
11 diff
(99.0 %id)
BQ647482 hepatocellular carcinoma, cell line, Liver .k 78 to 791 1 to 713       713/950
(75 %)
13 diff
(98.7 %id)
BQ648027 hepatocellular carcinoma, cell line, Liver .k 78 to 775 1 to 704       704/983
(71 %)
19 diff
(98.1 %id)
BQ892407 hepatocellular carcinoma, cell line, Liver .k 78 to 938 1 to 874       874/902
(96 %)
19 diff
(97.9 %id)
CR626381 Placenta Cot 25-normalized .k 79 to 1935 1 to 1857 exact tiling clone,   1857/1857
(100 %)
0 diff
(100 %id)
BX339422 Placenta Cot 25-normalized .k 79 to 986 1 to 905   fully sequenced,   905/905
(100 %)
2 diff
(99.8 %id)
TI_57237396   .k 79 to 911 68 to 904       837/904
(92 %)
21 diff
(97.7 %id)
BI909033 leukocyte .k 80 to 911 1 to 836       836/836
(100 %)
15 diff
(98.3 %id)
TI_57164399   .k 80 to 867 65 to 858       794/1001
(79 %)
15 diff
(98.6 %id)
BQ067024 brain .k 81 to 867 1 to 798       796/963
(82 %)
14 diff
(98.6 %id)
BQ958347 carcinoma, cell line, Prostate .k 81 to 867 1 to 789       789/931
(84 %)
17 diff
(98.2 %id)
BQ957685 carcinoma, cell line, Prostate .k 81 to 867 1 to 798       798/920
(86 %)
24 diff
(97.4 %id)
BQ920246 carcinoma, cell line, Prostate .k 81 to 869 1 to 792       792/946
(83 %)
4 diff
(99.6 %id)
BU931159 ovary, teratocarcinoma, cell line .k 81 to 838 1 to 767       767/816
(93 %)
14 diff
(98.3 %id)
CA454365   .k 82 to 867 1 to 788       788/886
(88 %)
4 diff
(99.6 %id)
BE871158 adenocarcinoma, colon .k 83 to 784 1 to 710       709/996
(71 %)
22 diff
(97.8 %id)
AA852697 Bone, Hip .k 83 to 371 9 to 296       288/296
(97 %)
3 diff
(99.0 %id)
DN997429 breast cancer, Mammary gland (cancer tissue) .k 83 to 731 8 to 656       649/656
(98 %)
0 diff
(100 %id)
ES312907 beard hair, skin .k 84 to 252 1 to 167       167/167
(100 %)
2 diff
(98.9 %id)
BG469122 adenocarcinoma cell line, colon .k 84 to 766 1 to 700       700/700
(100 %)
24 diff
(96.6 %id)
AA314558 colon .k 85 to 589 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
BI833926 pooled pancreas and spleen .k 85 to 867 1 to 789       789/932
(84 %)
9 diff
(99.1 %id)
BQ690777 ductal carcinoma, cell line, Pancreas .k 85 to 941 1 to 864       864/896
(96 %)
10 diff
(98.9 %id)
BQ691737 ductal carcinoma, cell line, Pancreas .k 85 to 955 1 to 880       880/881
(99 %)
15 diff
(98.3 %id)
BQ689297 ductal carcinoma, cell line, Pancreas .k 85 to 869 1 to 789       789/931
(84 %)
22 diff
(97.7 %id)
ES307772 beard hair, skin .k 87 to 228 1 to 142       142/142
(100 %)
2 diff
(98.6 %id)
BE265447 lung, small cell carcinoma .k 87 to 683 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BQ691488 ductal carcinoma, cell line, Pancreas .k 87 to 780 1 to 698       698/954
(73 %)
17 diff
(98.3 %id)
AA172138   .k 88 to 454 1 to 368       368/369
(99 %)
9 diff
(97.6 %id)
BE777968 eye, retinoblastoma .k 88 to 790 1 to 700       700/867
(80 %)
10 diff
(98.9 %id)
BE741047 adenocarcinoma cell line, ovary .k 88 to 873 1 to 783       783/1019
(76 %)
16 diff
(98.5 %id)
BE873520 adenocarcinoma, colon .k 89 to 880 1 to 804       800/844
(94 %)
47 diff
(94.5 %id)
BE277785 melanotic melanoma, skin .k 92 to 737 1 to 648       648/649
(99 %)
4 diff
(99.4 %id)
BE274389 melanotic melanoma, skin .k 92 to 863 1 to 770       770/770
(100 %)
6 diff
(99.3 %id)
BE275582 melanotic melanoma, skin .k 92 to 764 1 to 668       668/747
(89 %)
13 diff
(98.3 %id)
BE276320 melanotic melanoma, skin .k 92 to 771 1 to 675       675/764
(88 %)
11 diff
(98.6 %id)
BE275212 melanotic melanoma, skin .k 92 to 868 1 to 775       775/776
(99 %)
10 diff
(98.8 %id)
BE548855 cervical carcinoma cell line, cervix .k 92 to 764 1 to 671       671/672
(99 %)
4 diff
(99.5 %id)
BE389706 endometrium, adenocarcinoma cell line, uterus .k 92 to 749 1 to 655       655/658
(99 %)
15 diff
(97.8 %id)
BE390220 endometrium, adenocarcinoma cell line, uterus .k 92 to 642 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
BE407189 choriocarcinoma, placenta .k 92 to 705 1 to 613       613/714
(85 %)
7 diff
(99.1 %id)
BE796598 lung, small cell carcinoma .k 92 to 921 1 to 824       824/1054
(78 %)
15 diff
(98.6 %id)
BM924789 pooled colon, kidney, stomach .k 92 to 869 15 to 792       778/1144
(68 %)
11 diff
(99.1 %id)
TI_57150497   .k 92 to 792 73 to 784       712/1039
(68 %)
36 diff
(96.6 %id)
BG476202 melanotic melanoma, skin .k 94 to 963 1 to 880       880/1019
(86 %)
27 diff
(97.4 %id)
BG824710 adenocarcinoma cell line, colon .k 94 to 912 1 to 821       821/823
(99 %)
12 diff
(98.6 %id)
BE790064 large cell carcinoma, lung .k 95 to 747 1 to 656       654/656
(99 %)
17 diff
(97.5 %id)
AW732316 Kidney, renal cell adenocarcinoma .k 96 to 693 1 to 598   AAA   598/598
(100 %)
12 diff
(98.0 %id)
BG823352 adenocarcinoma cell line, colon .k 96 to 848 1 to 754       752/758
(99 %)
9 diff
(98.9 %id)
BE733766 choriocarcinoma, placenta .k 97 to 784 1 to 694       694/819
(84 %)
19 diff
(97.7 %id)
BE733887 choriocarcinoma, placenta .k 97 to 874 1 to 780       780/973
(80 %)
15 diff
(98.5 %id)
BE793536 lung, small cell carcinoma .k 97 to 874 1 to 778       778/985
(78 %)
13 diff
(98.7 %id)
BE900774 choriocarcinoma, placenta .k 97 to 791 1 to 694       694/915
(75 %)
10 diff
(99.0 %id)
BE902471 choriocarcinoma, placenta .k 97 to 783 1 to 680       680/681
(99 %)
10 diff
(98.6 %id)
BI762599 pooled colon, kidney, stomach .k 97 to 792 1 to 707       707/962
(73 %)
30 diff
(96.9 %id)
T35602 lung .k 97 to 441 1 to 350       350/352
(99 %)
9 diff
(97.5 %id)
CN409821 embryonic stem cells, DMSO-treated H9 cellline .k 99 to 450 1 to 352       352/352
(100 %)
0 diff
(100 %id)
BQ070989 brain, neuroblastoma, cell line .k 102 to 732 1 to 635       633/1320
(47 %)
9 diff
(99.4 %id)
BE407783 choriocarcinoma, placenta .k 107 to 620 1 to 514       514/514
(100 %)
5 diff
(99.1 %id)
BE262133 brain, neuroblastoma .k 108 to 756 1 to 647       647/648
(99 %)
3 diff
(99.6 %id)
AW401418 lymph .k 110 to 247 8 to 145       138/145
(95 %)
11 diff
(92.5 %id)
BE277319 melanotic melanoma, skin .k 113 to 784 1 to 666       666/792
(84 %)
19 diff
(97.7 %id)
BE409285 choriocarcinoma, placenta .k 113 to 765 1 to 649       649/721
(90 %)
5 diff
(99.4 %id)
BF172758 blood .k 114 to 239 1 to 135       135/135
(100 %)
18 diff
(86.7 %id)
BE389924 endometrium, adenocarcinoma cell line, uterus .k 114 to 792 1 to 674       674/730
(92 %)
32 diff
(95.7 %id)
BE740556 adenocarcinoma cell line, ovary .k 143 to 874 1 to 734       732/963
(76 %)
5 diff
(99.5 %id)
AL518565 brain, neuroblastoma, neuroblastoma cells .k 878 to 1952 1069 to 1       1069/1078
(99 %)
38 diff
(96.5 %id)
BX399257 Placenta Cot 25-normalized .k 925 to 1935 1004 to 1   fully sequenced,   1004/1004
(100 %)
10 diff
(99.1 %id)
BX340107 Placenta Cot 25-normalized .k 970 to 1900 957 to 31   fully sequenced,   927/957
(96 %)
5 diff
(99.5 %id)
BX414029 B cells (Ramos cell line) .k 1074 to 1962 893 to 1   fully sequenced,   893/893
(100 %)
29 diff
(96.8 %id)
AA171932   .k 1537 to 1963 457 to 29   tiling clone, AAA   429/429
(100 %)
9 diff
(98.0 %id)
NM_152931.1   .l 1 to 2172 1 to 2172 exact RefSeq, AAA   2172/2172
(100 %)
0 diff
(100 %id)
DA454872 tongue, tumor tissue .l 27 to 593 2 to 568   tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
DA756193   .l 28 to 349 2 to 323   capped   322/322
(100 %)
0 diff
(100 %id)
DA960141 Spleen .l 28 to 577 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB127272 thymus .l 28 to 580 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BF205941 brain, neuroblastoma .l 40 to 672 1 to 634       634/779
(81 %)
5 diff
(99.4 %id)
BI196645 brain, neuroblastoma .l 40 to 670 1 to 646       646/968
(66 %)
21 diff
(97.9 %id)
BC001142 Brain, neuroblastoma .l 41 to 2172 1 to 2132 exact tiling clone, available from MGC, AAA   2132/2132
(100 %)
0 diff
(100 %id)
BE312055 brain, neuroblastoma .l 60 to 637 1 to 586       586/586
(100 %)
10 diff
(98.3 %id)
BE261573 brain, neuroblastoma .l 60 to 672 1 to 613       613/711
(86 %)
8 diff
(98.9 %id)
BM730155 insulinoma, Pancreas .l 182 to 747 8 to 573       566/573
(98 %)
6 diff
(99.0 %id)
CA406609 adipose .l 337 to 898 1 to 561       561/561
(100 %)
4 diff
(99.3 %id)
BE391262 endometrium, adenocarcinoma cell line, uterus .l 363 to 984 42 to 659       619/711
(87 %)
28 diff
(96.1 %id)
CR456790   .l 364 to 1976 1 to 1613       1613/1614
(99 %)
3 diff
(99.9 %id)
CV025676 mixed .l 364 to 963 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
BM083707 B-cells, primary B-cells from tonsils (cell line) .l 364 to 1036 17 to 690       676/690
(97 %)
7 diff
(99.0 %id)
TI_1948086254   .l 364 to 1221 143 to 1006       864/1317
(65 %)
29 diff
(97.8 %id)
TI_1948086595   .l 364 to 1344 138 to 1117       980/1268
(77 %)
37 diff
(97.1 %id)
TI_1948086768   .l 364 to 1170 143 to 954       812/1365
(59 %)
39 diff
(97.2 %id)
BU159493 eye, retinoblastoma .l 376 to 1214 1 to 842       840/842
(99 %)
3 diff
(99.7 %id)
BE741034 adenocarcinoma cell line, ovary .l 377 to 1220 1 to 852       852/900
(94 %)
20 diff
(97.8 %id)
BI045326 prostate_normal .l 380 to 882 1 to 505       505/505
(100 %)
6 diff
(98.9 %id)
BI046961 prostate_normal .l 380 to 842 1 to 463       463/463
(100 %)
3 diff
(99.4 %id)
BG762831 melanotic melanoma, high MDR (cell line), skin .l 380 to 1091 1 to 711       711/712
(99 %)
3 diff
(99.6 %id)
BG767073 melanotic melanoma, high MDR (cell line), skin .l 380 to 1247 1 to 874       872/875
(99 %)
25 diff
(97.2 %id)
BE271495 adenocarcinoma cell line, ovary .l 412 to 914 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
BQ654308 hepatocellular carcinoma, cell line, Liver .l 416 to 1218 1 to 806       806/940
(85 %)
10 diff
(99.0 %id)
BQ939736 epidermoid carcinoma, cell line, lung .l 420 to 1226 35 to 844       810/926
(87 %)
16 diff
(98.3 %id)
BM461991 leiomyosarcoma, uterus .l 440 to 1226 1 to 790       790/930
(84 %)
5 diff
(99.5 %id)
BI085275 astrocytoma grade IV, cell line, brain .l 453 to 1176 1 to 736       734/920
(79 %)
25 diff
(97.3 %id)
BM910792 astrocytoma grade IV, cell line, brain .l 455 to 1076 1 to 621       621/1142
(54 %)
11 diff
(99.1 %id)
BM914026 astrocytoma grade IV, cell line, brain .l 456 to 1334 25 to 906       882/1156
(76 %)
18 diff
(98.5 %id)
AW409981 muscle, rhabdomyosarcoma .l 469 to 529 1 to 61       61/61
(100 %)
0 diff
(100 %id)
AW601883 breast .l 470 to 1083 48 to 662       615/668
(92 %)
10 diff
(98.6 %id)
BQ644663 hepatocellular carcinoma, cell line, Liver .l 471 to 1389 23 to 943       921/943
(97 %)
19 diff
(98.0 %id)
BQ650950 hepatocellular carcinoma, cell line, Liver .l 471 to 1335 19 to 886       868/949
(91 %)
22 diff
(97.7 %id)
BU839602 hepatocellular carcinoma, cell line, Liver .l 473 to 1312 1 to 845       845/876
(96 %)
7 diff
(99.3 %id)
BE385028 melanotic melanoma, skin .l 496 to 1004 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BQ049636 lymph, lymphoma, cell line .l 499 to 1220 1 to 725       725/1116
(64 %)
7 diff
(99.4 %id)
BG179574 adenocarcinoma, cell line, Prostate .l 505 to 1261 1 to 753       755/961
(78 %)
18 diff
(98.2 %id)
CU446744 epidermis .l 511 to 1121 13 to 623       611/631
(96 %)
10 diff
(98.5 %id)
CU447250 epidermis .l 511 to 1121 619 to 9     Submitted on the opposite strand 611/631
(96 %)
1 diff
(99.9 %id)
CU450880 epidermis .l 511 to 785 13 to 287       275/287
(95 %)
6 diff
(98.0 %id)
BG821740 adenocarcinoma cell line, colon .l 516 to 1311 1 to 800       800/800
(100 %)
9 diff
(98.9 %id)
CF122405 CNCAP(3)T-225 cell line, Prostate .l 526 to 1211 1 to 687       687/687
(100 %)
6 diff
(99.2 %id)
TI_154181985   .l 532 to 1339 84 to 891       808/892
(90 %)
15 diff
(98.4 %id)
BG747076 adenocarcinoma cell line, colon .l 541 to 1313 1 to 774       774/774
(100 %)
2 diff
(99.8 %id)
CN409816 embryonic stem cells, DMSO-treated H9 cellline .l 551 to 782 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
BE741099 adenocarcinoma cell line, ovary .l 557 to 1202 1 to 645       645/645
(100 %)
2 diff
(99.7 %id)
BE745229 adenocarcinoma cell line, ovary .l 558 to 1226 1 to 664       666/665
(100 %)
9 diff
(98.7 %id)
BE741854 adenocarcinoma cell line, ovary .l 566 to 1193 26 to 653       628/653
(96 %)
7 diff
(99.0 %id)
BM013288 brain, neuroblastoma, cell line .l 567 to 1334 1 to 765       765/765
(100 %)
35 diff
(95.5 %id)
BQ683837 melanotic melanoma, cell line, skin .l 568 to 1334 17 to 792       776/968
(80 %)
21 diff
(97.9 %id)
TI_59380167   .l 568 to 1334 117 to 880       764/764
(100 %)
34 diff
(95.6 %id)
CX762627 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .l 588 to 1323 1 to 730     Submitted on the opposite strand 730/860
(84 %)
14 diff
(98.4 %id)
AI937779 anaplastic oligodendroglioma, brain .l 594 to 1105 512 to 1       512/517
(99 %)
6 diff
(98.9 %id)
BG336882 leiomyosarcoma cell line, uterus .l 616 to 1376 755 to 1     Submitted on the opposite strand 755/969
(77 %)
20 diff
(98.0 %id)
BF312090 brain, neuroblastoma .l 619 to 1358 1 to 744       746/890
(83 %)
18 diff
(98.0 %id)
BQ072198 brain, neuroblastoma, cell line .l 621 to 1599 1 to 993       993/1044
(95 %)
25 diff
(97.7 %id)
AA304734 retina .l 627 to 1031 1 to 409       409/409
(100 %)
4 diff
(99.1 %id)
BG956092 colon .l 633 to 1054 427 to 7       421/427
(98 %)
1 diff
(99.8 %id)
CD359203 testis .l 635 to 1387 1 to 761       761/899
(84 %)
18 diff
(98.0 %id)
CX759101 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .l 637 to 1355 1 to 710       710/863
(82 %)
10 diff
(98.9 %id)
BF868475 lung_tumor .l 639 to 1083 482 to 36     Submitted on the opposite strand 447/492
(90 %)
6 diff
(98.8 %id)
BG034277 breast, mammary adenocarcinoma, cell line .l 648 to 1358 9 to 713       705/961
(73 %)
22 diff
(97.8 %id)
BG331963 large cell carcinoma, lung .l 658 to 1358 1 to 701       701/708
(99 %)
3 diff
(99.6 %id)
ES312618 frontal balding hair, skin .l 692 to 865 1 to 174       174/175
(99 %)
1 diff
(99.5 %id)
BF933534 nervous_tumor .l 696 to 1070 41 to 415       375/415
(90 %)
7 diff
(98.4 %id)
BQ217907 epithelioid carcinoma, Pancreas .l 702 to 1566 1 to 867       867/881
(98 %)
6 diff
(99.4 %id)
AA310312   .l 717 to 1008 1 to 292       292/292
(100 %)
0 diff
(100 %id)
BF035363 adenocarcinoma, ovary .l 719 to 1464 1 to 747       747/893
(83 %)
23 diff
(97.5 %id)
BQ368483 placenta_normal .l 729 to 1140 1 to 412       412/412
(100 %)
9 diff
(97.9 %id)
BG675177 skin .l 755 to 1572 1 to 818       818/821
(99 %)
4 diff
(99.6 %id)
BI820911 pooled brain, lung, testis .l 755 to 1595 1 to 840       840/848
(99 %)
12 diff
(98.6 %id)
TI_57197097   .l 755 to 1595 74 to 913       840/921
(91 %)
18 diff
(98.1 %id)
CD617696   .l 759 to 1326 580 to 13       568/589
(96 %)
5 diff
(99.2 %id)
CN409817 embryonic stem cells, cell lines H1, H7, andH9 .l 766 to 1479 1 to 714       714/714
(100 %)
1 diff
(99.9 %id)
CD617695   .l 772 to 1326 1 to 555       555/568
(97 %)
1 diff
(99.9 %id)
BF838847 head_neck .l 786 to 1117 1 to 331       331/333
(99 %)
4 diff
(98.8 %id)
BM424008 amelanotic melanoma, cell line, skin .l 793 to 1720 1 to 930       929/1011
(91 %)
24 diff
(97.7 %id)
BM424090 amelanotic melanoma, cell line, skin .l 793 to 1715 1 to 933       931/967
(96 %)
21 diff
(97.9 %id)
H65964 liver and spleen .l 799 to 1128 1 to 330       330/330
(100 %)
2 diff
(99.4 %id)
BM471406 leiomyosarcoma, uterus .l 800 to 1567 1 to 774       774/1121
(69 %)
22 diff
(98.1 %id)
BQ227517 embryonal carcinoma, cell line, testis .l 800 to 1595 1 to 798       798/862
(92 %)
3 diff
(99.7 %id)
H52034 brain .l 803 to 1056 1 to 257       257/257
(100 %)
4 diff
(98.5 %id)
CF145992 CNCAP(3)T-225 cell line, Prostate .l 814 to 1341 1 to 527       526/527
(99 %)
5 diff
(99.1 %id)
AA357591 Prostate .l 818 to 1031 1 to 214       214/214
(100 %)
2 diff
(99.1 %id)
AA838086 ovary .l 818 to 1116 299 to 1       299/309
(96 %)
1 diff
(99.7 %id)
AA838152 ovary .l 818 to 1116 299 to 1       299/309
(96 %)
2 diff
(99.4 %id)
BE387314 melanotic melanoma, skin .l 818 to 1446 79 to 706       630/707
(89 %)
9 diff
(98.8 %id)
BU839501 hepatocellular carcinoma, cell line, Liver .l 818 to 1692 9 to 899       893/979
(91 %)
43 diff
(95.7 %id)
BF206259 brain, neuroblastoma .l 820 to 1655 1 to 831       831/873
(95 %)
37 diff
(95.8 %id)
BG392555 embryonal carcinoma, cell line, testis .l 820 to 1466 1 to 644       644/918
(70 %)
6 diff
(99.4 %id)
TI_154178275   .l 822 to 1358 81 to 617       537/546
(98 %)
0 diff
(100 %id)
BG013084 placenta_normal .l 829 to 1083 293 to 38       256/293
(87 %)
0 diff
(100 %id)
AL597697   .l 831 to 1153 1 to 323       323/323
(100 %)
0 diff
(100 %id)
BG468634 adenocarcinoma cell line, colon .l 835 to 1639 1 to 807       807/808
(99 %)
27 diff
(96.7 %id)
BG478711 melanotic melanoma, skin .l 836 to 1718 1 to 899       855/901
(94 %)
35 diff
(96.2 %id)
BF870128 lung_tumor .l 853 to 1358 518 to 13     Submitted on the opposite strand 506/541
(93 %)
8 diff
(98.6 %id)
R93251 liver and spleen .l 872 to 1224 1 to 357       357/407
(87 %)
11 diff
(97.3 %id)
TI_59391492   .l 893 to 1682 64 to 853       790/791
(99 %)
5 diff
(99.4 %id)
BM013589 breast, mammary adenocarcinoma, cell line .l 894 to 1682 1 to 789       789/790
(99 %)
5 diff
(99.4 %id)
AA127315 lung, lung carcinoma .l 895 to 1255 1 to 361       362/361
(100 %)
5 diff
(98.7 %id)
BF689683 melanotic melanoma, high MDR (cell line), skin .l 910 to 1630 1 to 724   fully sequenced,   724/724
(100 %)
15 diff
(98.0 %id)
BG767024 melanotic melanoma, high MDR (cell line), skin .l 910 to 1699 1 to 791       791/791
(100 %)
24 diff
(97.0 %id)
BI053314 placenta_normal .l 916 to 1387 1 to 472       472/473
(99 %)
3 diff
(99.4 %id)
BQ956074 epidermoid carcinoma, cell line, lung .l 936 to 1739 1 to 809       809/914
(88 %)
9 diff
(99.1 %id)
BE548646 cervical carcinoma cell line, cervix .l 938 to 1565 1 to 620       622/767
(81 %)
15 diff
(98.1 %id)
BM687541 eye, eye anterior segment .l 942 to 1449 6 to 514       509/514
(99 %)
7 diff
(98.7 %id)
BE541162 cervix .l 950 to 1657 1 to 716       715/856
(83 %)
33 diff
(96.2 %id)
CD245961 White Matter .l 956 to 1774 1 to 827       827/876
(94 %)
11 diff
(98.8 %id)
CN409823 embryonic stem cells, DMSO-treated H9 cellline .l 961 to 1628 1 to 670       670/670
(100 %)
9 diff
(98.7 %id)
BI115875 lung, small cell carcinoma .l 984 to 1710 2 to 723       724/723
(100 %)
9 diff
(98.8 %id)
BF770932 epid_tumor .l 985 to 1443 1 to 459       459/459
(100 %)
12 diff
(97.4 %id)
BF798528 colon_ins .l 997 to 1369 1 to 373       373/373
(100 %)
4 diff
(99.0 %id)
BI254653 cervical carcinoma cell line, cervix .l 999 to 1714 1 to 716       716/716
(100 %)
5 diff
(99.4 %id)
CX787278 human embryonic stem cells .l 999 to 1726 1 to 728       728/728
(100 %)
1 diff
(99.9 %id)
BU959818 mixed (pool of 40 RNAs) .l 1003 to 1599 1 to 601       601/868
(69 %)
15 diff
(98.3 %id)
BG763413 melanotic melanoma, high MDR (cell line), skin .l 1008 to 1675 1 to 668       668/670
(99 %)
2 diff
(99.8 %id)
BG333776 melanotic melanoma, skin .l 1017 to 1756 1 to 738       740/846
(87 %)
22 diff
(97.4 %id)
BQ083180 Ascites, stomach .l 1017 to 1426 1 to 409       409/409
(100 %)
3 diff
(99.3 %id)
AA328965   .l 1028 to 1375 1 to 350       348/350
(99 %)
4 diff
(98.9 %id)
BE277148 melanotic melanoma, skin .l 1037 to 1763 1 to 727       727/771
(94 %)
5 diff
(99.4 %id)
BE409007 choriocarcinoma, placenta .l 1037 to 1626 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BE746909 adenocarcinoma cell line, ovary .l 1042 to 1817 1 to 775       775/942
(82 %)
11 diff
(98.9 %id)
BE081790 breast .l 1051 to 1423 1 to 372       372/372
(100 %)
8 diff
(97.9 %id)
BG258967 embryonal carcinoma, cell line, testis .l 1056 to 1599 1 to 544       544/1044
(52 %)
5 diff
(99.6 %id)
BG149403 carcinoid, lung .l 1059 to 1722 1 to 664     Submitted on the opposite strand 664/664
(100 %)
8 diff
(98.8 %id)
BM730035 insulinoma, Pancreas .l 1068 to 1633 8 to 573       566/573
(98 %)
0 diff
(100 %id)
CK823929 insulinoma, Pancreas .l 1068 to 1635 8 to 575       568/575
(98 %)
2 diff
(99.7 %id)
BI224610 cervical carcinoma cell line, cervix .l 1072 to 1837 31 to 804       780/809
(96 %)
19 diff
(97.7 %id)
BE535850 cervix .l 1085 to 1766 1 to 701       646/1125
(57 %)
31 diff
(97.3 %id)
BQ918101 epidermoid carcinoma, cell line, lung .l 1096 to 1837 1 to 747       747/859
(86 %)
7 diff
(99.2 %id)
BQ331908 lung_tumor .l 1099 to 1453 1 to 354       354/357
(99 %)
9 diff
(97.5 %id)
BY997607   .l 1109 to 1807 1 to 699       699/699
(100 %)
2 diff
(99.8 %id)
AI940455 colon .l 1126 to 1611 1 to 489       489/489
(100 %)
14 diff
(97.2 %id)
BE736780 adenocarcinoma, Pancreas .l 1131 to 1845 1 to 716       716/879
(81 %)
12 diff
(98.7 %id)
BM796742 Ascites, stomach .l 1147 to 1649 1 to 503       503/503
(100 %)
0 diff
(100 %id)
BG324569 Kidney, renal cell adenocarcinoma .l 1152 to 1946 1 to 778       778/943
(82 %)
29 diff
(97.0 %id)
BE736319 adenocarcinoma, Pancreas .l 1157 to 1845 8 to 695       693/828
(83 %)
29 diff
(96.5 %id)
BQ647749 hepatocellular carcinoma, cell line, Liver .l 1157 to 2010 1 to 860       863/932
(92 %)
27 diff
(97.2 %id)
H53482 liver and spleen .l 1165 to 1582 1 to 429       429/429
(100 %)
14 diff
(96.8 %id)
TI_59393090   .l 1168 to 1814 93 to 747       655/897
(73 %)
24 diff
(97.4 %id)
AA353954   .l 1169 to 1591 1 to 427       427/427
(100 %)
5 diff
(98.9 %id)
BF809031 colon_ins .l 1169 to 1487 318 to 1     Submitted on the opposite strand 318/318
(100 %)
4 diff
(98.8 %id)
BM014992 breast, mammary adenocarcinoma, cell line .l 1170 to 1814 1 to 653       653/895
(72 %)
24 diff
(97.4 %id)
AI908153 breast .l 1173 to 1677 5 to 508       504/508
(99 %)
6 diff
(98.9 %id)
AA411545 ovarian tumor, ovary .l 1202 to 1743 1 to 542       542/542
(100 %)
7 diff
(98.8 %id)
BF883794 lung_tumor .l 1215 to 1859 645 to 1     Submitted on the opposite strand 645/645
(100 %)
3 diff
(99.6 %id)
BI033489 nervous_normal .l 1216 to 1825 627 to 13       615/647
(95 %)
17 diff
(97.4 %id)
BF883791 lung_tumor .l 1225 to 1859 635 to 1     Submitted on the opposite strand 635/637
(99 %)
2 diff
(99.7 %id)
BG990594 head_neck .l 1244 to 1880 1 to 631       631/638
(98 %)
17 diff
(97.4 %id)
BE073500 breast .l 1245 to 1444 1 to 200       200/200
(100 %)
1 diff
(99.5 %id)
BE073504 breast .l 1245 to 1444 200 to 1     Submitted on the opposite strand 200/200
(100 %)
0 diff
(100 %id)
BE073508 breast .l 1245 to 1448 1 to 204       204/204
(100 %)
1 diff
(99.6 %id)
BE073582 breast .l 1245 to 1442 198 to 1     Submitted on the opposite strand 198/198
(100 %)
2 diff
(99.0 %id)
BE073642 breast .l 1245 to 1444 1 to 200       200/200
(100 %)
0 diff
(100 %id)
BE693889 breast .l 1245 to 1442 198 to 1       198/198
(100 %)
1 diff
(99.5 %id)
BE693898 breast .l 1245 to 1444 1 to 200       200/200
(100 %)
2 diff
(99.0 %id)
BE693908 breast .l 1245 to 1436 192 to 1       192/192
(100 %)
4 diff
(98.0 %id)
BF870874 lung_tumor .l 1258 to 1764 1 to 504       507/504
(100 %)
9 diff
(98.3 %id)
BE893922 melanotic melanoma, skin .l 1281 to 2057 1 to 758       758/811
(93 %)
63 diff
(92.3 %id)
CB156206 Liver .l 1324 to 1711 1 to 388       388/388
(100 %)
0 diff
(100 %id)
AW374402 colon .l 1335 to 1664 1 to 330       330/330
(100 %)
1 diff
(99.7 %id)
AA464319 ovarian tumor, ovary .l 1353 to 1730 17 to 390       377/390
(96 %)
17 diff
(95.7 %id)
BF770938 epid_tumor .l 1365 to 1872 507 to 1     Submitted on the opposite strand 507/507
(100 %)
2 diff
(99.7 %id)
AW379458 head_neck .l 1376 to 1946 1 to 570       570/588
(96 %)
9 diff
(98.5 %id)
BP431147   .l 1391 to 1807 1 to 421       421/421
(100 %)
8 diff
(98.1 %id)
AA353966   .l 1403 to 1639 1 to 239       239/239
(100 %)
3 diff
(98.8 %id)
TI_1948086255   .l 1411 to 1976 693 to 124       570/1347
(42 %)
28 diff
(98.0 %id)
TI_1948086596   .l 1411 to 1976 684 to 115       568/1390
(40 %)
18 diff
(98.8 %id)
TI_154124855   .l 1417 to 2172 838 to 96   AAA   743/911
(81 %)
18 diff
(98.1 %id)
EC500266 Prostate .l 1428 to 1535 109 to 2       108/110
(98 %)
0 diff
(100 %id)
BP428785   .l 1429 to 1788 7 to 366       360/366
(98 %)
6 diff
(98.4 %id)
BM689655 eye, Retina Foveal and Macular .l 1432 to 1729 9 to 306       298/306
(97 %)
6 diff
(98.1 %id)
AW409982 muscle, rhabdomyosarcoma .l 1527 to 2172 671 to 26   AAA   646/646
(100 %)
2 diff
(99.7 %id)
BM511807 insulinoma, Pancreas .l 1561 to 2172 628 to 17   AAA   612/612
(100 %)
0 diff
(100 %id)
BG403218 bladder, transitional cell papilloma, cell line .l 1563 to 2172 1 to 619   AAA   598/619
(96 %)
13 diff
(97.9 %id)
BF690578 melanotic melanoma, high MDR (cell line), skin .l 1595 to 2109 531 to 13   fully sequenced,   519/531
(97 %)
7 diff
(98.7 %id)
BM970442 lung .l 1596 to 2172 595 to 19   AAA   577/577
(100 %)
0 diff
(100 %id)
EC565840 Prostate .l 1607 to 1690 1 to 84       84/84
(100 %)
0 diff
(100 %id)
BF081896 amnion_normal .l 1612 to 1826 1 to 215       215/215
(100 %)
3 diff
(98.7 %id)
BP431502   .l 1613 to 1931 1 to 323       323/323
(100 %)
3 diff
(99.1 %id)
AA936223 adenocarcinoma, colon .l 1669 to 1763 94 to 1       94/94
(100 %)
2 diff
(97.9 %id)
EC577866 Prostate .l 1703 to 1792 90 to 1       90/90
(100 %)
0 diff
(100 %id)
AA605277 adrenal adenoma, adrenal gland .l 1717 to 1981 261 to 1       261/261
(100 %)
5 diff
(98.1 %id)
EC531614 Prostate .l 1766 to 1862 1 to 95       95/95
(100 %)
2 diff
(97.9 %id)
AA127316 lung, lung carcinoma .l 1787 to 2146 360 to 1       360/360
(100 %)
1 diff
(99.8 %id)
H24273.
matches multiple genes
whole brain .l 1827 to 2172 360 to 13   AAA also hits gene glorzorbu 348/348
(100 %)
15 diff
(95.7 %id)
AA775385 whole brain .l 1838 to 2172 380 to 47   AAA   334/335
(99 %)
1 diff
(99.8 %id)
BQ027597 mixed .l 1853 to 2172 338 to 19   AAA   320/320
(100 %)
0 diff
(100 %id)
BG686871 B-cells, primary B-cells from tonsils (cell line) .l 1854 to 2172 1 to 318   AAA   318/318
(100 %)
1 diff
(99.7 %id)
H53857 liver and spleen .l 1861 to 2151 291 to 1       291/291
(100 %)
12 diff
(95.9 %id)
AI202078 anaplastic oligodendroglioma, brain .l 1864 to 2048 184 to 1       184/184
(100 %)
4 diff
(97.9 %id)
AA455135 ovarian tumor, ovary .l 1869 to 2172 318 to 16   AAA   303/303
(100 %)
6 diff
(98.1 %id)
BI766175 pooled lung and spleen .l 1879 to 2172 1 to 293   AAA   293/293
(100 %)
1 diff
(99.7 %id)
R93158 liver and spleen .l 1907 to 2159 256 to 3       254/256
(99 %)
0 diff
(100 %id)
AA485505 ovarian tumor, ovary .l 1936 to 2154 1 to 220   fully sequenced,   220/220
(100 %)
1 diff
(99.6 %id)
BM661623 eye, Retina Foveal and Macular .l 1942 to 2172 249 to 19   AAA   231/231
(100 %)
3 diff
(98.8 %id)
AA485350 ovarian tumor, ovary .l 2047 to 2172 125 to 1   fully sequenced,   125/125
(100 %)
0 diff
(100 %id)
H49449 brain .m 1 to 428 5 to 434   tiling clone,   434/435
(99 %)
15 diff
(96.6 %id)
H49450 brain .m 1309 to 1745 438 to 1   tiling clone,   438/438
(100 %)
8 diff
(98.2 %id)
CB216201 normal endometrium, mid-secretory phase,cycle day 23, uterus .n 1 to 590 13 to 602   tiling clone,   590/590
(100 %)
0 diff
(100 %id)
DQ656050   .n 577 to 1448 1 to 872   tiling clone,   872/872
(100 %)
0 diff
(100 %id)
DQ655945   .n 640 to 1454 1 to 815       815/824
(98 %)
7 diff
(99.2 %id)
AB209827 brain .n 894 to 2830 1 to 1937 exact tiling clone,   1937/1937
(100 %)
0 diff
(100 %id)
CX785016 human embryonic stem cells .n 962 to 1088 1 to 127       127/127
(100 %)
1 diff
(99.3 %id)
BF850957 lung_normal .n 1110 to 1402 1 to 293       293/295
(99 %)
4 diff
(98.7 %id)
CB148044 Liver .n 1148 to 1267 11 to 130       120/130
(92 %)
7 diff
(94.7 %id)
ES307584 beard hair, skin .n 1230 to 1394 1 to 165       165/165
(100 %)
0 diff
(100 %id)
BG756092 B-cells, primary B-cells from tonsils (cell line) .n 1358 to 2247 1 to 887       887/892
(99 %)
38 diff
(95.8 %id)
CR606579 T cells (Jurkat cell line) .o 1 to 1695 1 to 1695 exact tiling clone,   1695/1695
(100 %)
0 diff
(100 %id)
BM808412 ovary (pool of 3) .p -8 to 979 11 to 1005       995/1080
(92 %)
29 diff
(97.4 %id)
BP195880 brain .p 1 to 582 2 to 583       583/583
(100 %)
0 diff
(100 %id)
AF097025   .p 1 to 2093 2 to 2092 A5V A47T R412A K431N AAA   2092/2092
(100 %)
17 diff
(99.2 %id)
AK312293 cerebellum .p 1 to 1437 2 to 1438 A5V N245S     1438/1438
(100 %)
3 diff
(99.8 %id)
DA170422 amygdala .p 1 to 531 3 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA463652   .p 1 to 552 3 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BP282335 bone marrow .p 1 to 587 2 to 588       588/588
(100 %)
0 diff
(100 %id)
CB111070 Liver .p 1 to 518 2 to 519       519/519
(100 %)
0 diff
(100 %id)
NM_021100.3   .p 1 to 2370 2 to 2371 exact RefSeq,   2371/2371
(100 %)
0 diff
(100 %id)
BP309981 brain .p 1 to 582 2 to 583       583/583
(100 %)
0 diff
(100 %id)
DA001321   .p 1 to 508 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
DA008876 adrenal gland .p 1 to 862 2 to 863   capped   862/863
(99 %)
13 diff
(98.5 %id)
DA010751 adrenal gland .p 1 to 570 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA011081 adrenal gland .p 1 to 561 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA011389 adrenal gland .p 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA013190 adrenal gland .p 1 to 551 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
AK001265   .p 1 to 2093 1 to 2092 T298H L300* tiling clone, available from FLJ,   2092/2092
(100 %)
2 diff
(100.0 %id)
AK223239 stomach mucosa .p 1 to 1938 1 to 1938 P50S     1938/1938
(100 %)
1 diff
(100.0 %id)
DA026480   .p 1 to 575 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA029708   .p 1 to 579 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA035051 breast .p 1 to 552 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA053728   .p 1 to 578 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA053765   .p 1 to 605 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DA056947 cerebellum .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA065684 cerebellum .p 1 to 331 2 to 332   capped   331/331
(100 %)
0 diff
(100 %id)
DA071543 cerebellum .p 1 to 578 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA074140 cerebellum .p 1 to 575 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA077314 cerebellum .p 1 to 568 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA135930 alzheimer cortex .p 1 to 545 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA138593 alzheimer cortex .p 1 to 551 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA142001 alzheimer cortex .p 1 to 545 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA144717 amygdala .p 1 to 561 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA154683 amygdala .p 1 to 470 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DA155955 amygdala .p 1 to 470 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DA159462 amygdala .p 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA169492 amygdala .p 1 to 575 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA170652 amygdala .p 1 to 581 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA170921 amygdala .p 1 to 560 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA178448 amygdala .p 1 to 552 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA204006 brain .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA252797 caudate nucleus .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA257564 caudate nucleus .p 1 to 568 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA263656 caudate nucleus .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA267562 caudate nucleus .p 1 to 523 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DA278013 corpus callosum .p 1 to 554 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA288866 hippocampus .p 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA295740 hippocampus .p 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA344071 substantia nigra .p 1 to 565 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA357728 subthalamic nucleus .p 1 to 570 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA369958 subthalamic nucleus .p 1 to 571 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA370897 thalamus .p 1 to 553 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA381950 thalamus .p 1 to 555 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA383966 thalamus .p 1 to 570 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA384535 thalamus .p 1 to 588 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA476550   .p 1 to 572 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA482020   .p 1 to 592 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA499680 brain .p 1 to 548 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA512149 brain .p 1 to 561 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA537089 heart .p 1 to 571 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA538356 Kidney .p 1 to 590 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA560490 heart .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA563877 heart .p 1 to 208 2 to 209   capped   208/208
(100 %)
0 diff
(100 %id)
DA574021   .p 1 to 565 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA574361   .p 1 to 547 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA574615   .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA580225   .p 1 to 546 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA588027 lung .p 1 to 582 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA601697   .p 1 to 562 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA601785   .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA620960   .p 1 to 590 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA621409 Kidney .p 1 to 575 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA630975 Kidney .p 1 to 580 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA631380 Kidney .p 1 to 565 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA631442 Kidney .p 1 to 580 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA631618 Kidney .p 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA634816 Kidney .p 1 to 576 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA635829 Kidney .p 1 to 567 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA641036 Liver .p 1 to 545 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA647817   .p 1 to 565 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA665196   .p 1 to 536 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA678403   .p 1 to 567 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA686406   .p 1 to 545 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA701138   .p 1 to 462 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
DA707705   .p 1 to 574 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA718680   .p 1 to 543 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AU124910   .p 1 to 801 2 to 804   capped   803/803
(100 %)
11 diff
(98.7 %id)
DA748130   .p 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA765435 tongue .p 1 to 568 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA821911 pericardium .p 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA837789 placenta .p 1 to 272 2 to 273   capped   272/272
(100 %)
0 diff
(100 %id)
DA849241 placenta .p 1 to 569 2 to 570   capped   569/571
(99 %)
2 diff
(99.7 %id)
DA874252 Prostate .p 1 to 558 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA882142   .p 1 to 579 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA912083   .p 1 to 563 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA919697 small intestine .p 1 to 565 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA921320 small intestine .p 1 to 554 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA924520 small intestine .p 1 to 574 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA928491 small intestine .p 1 to 574 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA946988 Spleen .p 1 to 575 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA982486 synovial membrane tissue from rheumatioidarthritis .p 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB006077 breast, tumor tissue .p 1 to 554 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB015197 esophageal, tumor tissue .p 1 to 565 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB016827 esophageal, tumor tissue .p 1 to 559 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB017691 esophageal, tumor tissue .p 1 to 575 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB032189 testis .p 1 to 586 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB033360 testis .p 1 to 551 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB035653 testis .p 1 to 567 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB118861 thymus .p 1 to 555 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB126645 thymus .p 1 to 543 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB130388 thymus .p 1 to 544 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB183289 liver, tumor tissue .p 1 to 563 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB208991 trachea .p 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB245800 uterus, tumor tissue .p 1 to 574 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB247896 uterus .p 1 to 521 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
BP197937 adrenal gland .p 2 to 582 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA062196 cerebellum .p 2 to 569 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA163515 amygdala .p 2 to 498 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
DA372538 thalamus .p 2 to 569 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AU124736   .p 2 to 854 2 to 853   capped   852/861
(98 %)
8 diff
(99.1 %id)
AL515484 brain, neuroblastoma, neuroblastoma cells .p 4 to 985 15 to 984       970/984
(98 %)
19 diff
(98.1 %id)
BM546535 brain, hippocampus .p 4 to 983 13 to 1004       992/1134
(87 %)
38 diff
(96.7 %id)
TI_57217205   .p 5 to 854 28 to 879       850/1020
(83 %)
21 diff
(98.0 %id)
BP222886   .p 8 to 589 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AU129287   .p 8 to 593 18 to 602   capped   585/585
(100 %)
8 diff
(98.7 %id)
DA355189 subthalamic nucleus .p 9 to 521 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA694210   .p 9 to 582 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA056781 cerebellum .p 10 to 554 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA267254 caudate nucleus .p 10 to 563 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB045488 testis .p 10 to 562 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB124119 thymus .p 10 to 581 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BI754575 brain .p 12 to 914 1 to 907       905/987
(91 %)
32 diff
(96.8 %id)
BQ073152 leukocyte .p 13 to 921 1 to 914       913/1028
(88 %)
16 diff
(98.5 %id)
CN432040 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 14 to 823 1 to 810       810/810
(100 %)
1 diff
(99.9 %id)
BC065560 Pancreas, epithelioid carcinoma .p 15 to 2093 1 to 2079 exact available from MGC, AAA   2079/2079
(100 %)
1 diff
(100.0 %id)
BQ925327 sciatic nerve .p 19 to 849 1 to 834       834/856
(97 %)
6 diff
(99.3 %id)
AK001470   .p 24 to 2370 34 to 2380 exact tiling clone, available from FLJ,   2347/2347
(100 %)
0 diff
(100 %id)
DB031499 testis .p 25 to 521 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
TI_1948216113   .p 63 to 687 127 to 751   fully sequenced,   625/751
(83 %)
7 diff
(99.1 %id)
TI_1948216273   .p 63 to 749 127 to 813   fully sequenced,   687/813
(84 %)
8 diff
(99.1 %id)
TI_1948216433   .p 63 to 749 128 to 814   fully sequenced,   687/814
(84 %)
7 diff
(99.2 %id)
TI_1948216590   .p 63 to 749 125 to 814   fully sequenced,   690/814
(84 %)
8 diff
(99.1 %id)
CN432037 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 65 to 453 1 to 389       389/389
(100 %)
0 diff
(100 %id)
DA962860 stomach .p 189 to 752 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BM452489 eye, retinoblastoma .p 192 to 1089 1 to 912       912/1018
(89 %)
22 diff
(97.9 %id)
AW651714 cervical carcinoma cell line, cervix .p 326 to 618 1 to 293       293/293
(100 %)
3 diff
(99.0 %id)
AU139449 placenta .p 348 to 1016 2 to 670   capped   669/725
(92 %)
7 diff
(99.1 %id)
AJ010952   .p 479 to 2093 1 to 1615   AAA   1615/1615
(100 %)
0 diff
(100 %id)
F12405 brain, total brain .p 479 to 836 1 to 358       358/358
(100 %)
0 diff
(100 %id)
BQ228630 embryonal carcinoma, cell line, testis .p 504 to 1295 1 to 793       793/901
(88 %)
8 diff
(99.2 %id)
DR762375 embryonic stem .p 559 to 1363 1 to 805       805/805
(100 %)
0 diff
(100 %id)
CF139792 CNCAP(3)T-225 cell line, Prostate .p 618 to 1118 8 to 508       501/508
(98 %)
0 diff
(100 %id)
CD671950 eye, Iris .p 631 to 1279 1 to 649       649/649
(100 %)
0 diff
(100 %id)
TI_1948216114   .p 657 to 1436 900 to 119   fully sequenced,   782/900
(86 %)
2 diff
(99.8 %id)
TI_1948216274   .p 688 to 1436 873 to 123   fully sequenced,   751/873
(86 %)
0 diff
(100 %id)
TI_1948216434   .p 688 to 1436 871 to 122   fully sequenced,   750/871
(86 %)
1 diff
(99.9 %id)
TI_1948216591   .p 688 to 1436 875 to 124   fully sequenced,   752/875
(85 %)
9 diff
(99.0 %id)
CA454242   .p 822 to 1699 1 to 883       883/885
(99 %)
10 diff
(98.9 %id)
R55097 whole brain .p 867 to 984 1 to 118       118/118
(100 %)
0 diff
(100 %id)
BQ220871 melanotic melanoma, skin .p 1010 to 1828 28 to 847       821/847
(96 %)
9 diff
(99.0 %id)
BX395003 Neuroblastoma Cot 25-normalized .p 1011 to 2064 1050 to 1       1050/1050
(100 %)
11 diff
(99.0 %id)
AA262011 germinal center B cell .p 1031 to 1484 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BE897611 melanotic melanoma, skin .p 1034 to 1775 1 to 745       745/745
(100 %)
6 diff
(99.2 %id)
BX370301   .p 1070 to 2022 1 to 952       952/952
(100 %)
31 diff
(96.8 %id)
BX405100 T cells (Jurkat cell line) .p 1114 to 2066 958 to 1       958/958
(100 %)
13 diff
(98.7 %id)
AL515483 brain, neuroblastoma, neuroblastoma cells .p 1198 to 2007 822 to 12       811/822
(98 %)
15 diff
(98.2 %id)
TI_57239691   .p 1245 to 2169 18 to 947       930/947
(98 %)
19 diff
(98.0 %id)
BI916172 brain .p 1258 to 2169 1 to 918       918/918
(100 %)
14 diff
(98.5 %id)
TI_149300584   .p 1295 to 2093 885 to 89   AAA   797/962
(82 %)
12 diff
(98.8 %id)
BM704466 eye, Retina Foveal and Macular .p 1333 to 1676 1 to 345   fully sequenced,   345/345
(100 %)
0 diff
(100 %id)
TI_149307661   .p 1374 to 2093 809 to 93   AAA   717/949
(75 %)
4 diff
(99.6 %id)
BM792343 Ascites, stomach .p 1375 to 1934 1 to 560       560/560
(100 %)
0 diff
(100 %id)
TI_151734469   .p 1433 to 2093 739 to 79   AAA   661/953
(69 %)
2 diff
(99.8 %id)
BM976626 lung, Primary Lung Cystic Fibrosis EpithelialCells .p 1437 to 2093 675 to 19   AAA   657/657
(100 %)
1 diff
(99.9 %id)
BM979406 lung, Primary Lung Epithelial Cells .p 1438 to 2093 674 to 19   AAA   656/656
(100 %)
1 diff
(99.9 %id)
BM723224 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .p 1439 to 2093 1 to 654   fully sequenced, AAA   654/654
(100 %)
4 diff
(99.4 %id)
AI609204 normal gingiva (cell line from primarykeratinocytes) .p 1524 to 2093 570 to 1       570/570
(100 %)
0 diff
(100 %id)
AU148535   .p 1535 to 2093 558 to 1       558/558
(100 %)
12 diff
(97.9 %id)
BM711801 eye, human retina .p 1541 to 2095 1 to 555   AAA   555/555
(100 %)
0 diff
(100 %id)
AA902946 leiomyosarcoma, soft tissue .p 1545 to 2093 564 to 16   AAA   549/549
(100 %)
0 diff
(100 %id)
BF939784 brain, glioblastoma (pooled) .p 1553 to 2093 541 to 1       541/541
(100 %)
0 diff
(100 %id)
DB328691 placenta .p 1555 to 2093 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
AW673175 cervical carcinoma cell line, cervix .p 1580 to 2094 515 to 1       515/515
(100 %)
0 diff
(100 %id)
DB362658   .p 1583 to 2093 505 to 1       505/555
(90 %)
8 diff
(98.6 %id)
AU158024 placenta .p 1605 to 2093 489 to 1       489/490
(99 %)
8 diff
(98.4 %id)
BU736632 eye, Retina Foveal and Macular .p 1646 to 2093 466 to 19   fully sequenced, AAA   448/448
(100 %)
0 diff
(100 %id)
BP418024 small intestine .p 1647 to 2093 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
BM800087 leiomyosarcoma, uterus .p 1649 to 2093 1 to 445   AAA   445/445
(100 %)
0 diff
(100 %id)
AA707993 pineal gland .p 1679 to 2093 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI214202 adenocarcinoma, colon .p 1682 to 2093 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AW512222 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p 1685 to 2094 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI041708 parathyroid gland, parathyroid tumor .p 1689 to 2095 417 to 11   AAA   407/407
(100 %)
0 diff
(100 %id)
AI471710 colon, moderately-differentiated adenocarcinoma .p 1698 to 2093 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AA291215 germinal center B cell .p 1708 to 2093 386 to 1       386/387
(99 %)
0 diff
(100 %id)
BM682446 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .p 1721 to 2093 391 to 19   fully sequenced, AAA   373/373
(100 %)
0 diff
(100 %id)
DB295125 adrenal gland .p 1729 to 2093 365 to 1       365/365
(100 %)
5 diff
(98.7 %id)
F10023 brain, total brain .p 1735 to 2093 359 to 1       359/359
(100 %)
0 diff
(100 %id)
FN137994 breast carcinoma .p 1763 to 1845 80 to 1     Submitted on the opposite strand 80/84
(95 %)
3 diff
(96.5 %id)
AA533896 normal prostatic epithelial cells, Prostate .p 1773 to 2093 325 to 6       320/556
(57 %)
0 diff
(100 %id)
AA832096 germinal center B cell .p 1775 to 2093 360 to 42   AAA   319/319
(100 %)
0 diff
(100 %id)
AU151445   .p 1784 to 2370 588 to 1       588/588
(100 %)
4 diff
(99.4 %id)
AI631579 pooled germ cell tumors .p 2135 to 2360 226 to 1       226/226
(100 %)
0 diff
(100 %id)
BG387145 adenocarcinoma cell line, colon .q 1 to 746 1 to 754   tiling clone,   752/757
(99 %)
21 diff
(97.3 %id)
R95478   .q 29 to 183 1 to 152   tiling clone,   152/155
(98 %)
3 diff
(98.1 %id)
AW732800 choriocarcinoma, placenta .q 76 to 499 1 to 424   tiling clone,   424/424
(100 %)
6 diff
(98.6 %id)
BE208781 choriocarcinoma, placenta .q 1171 to 1720 550 to 1   tiling clone,   550/550
(100 %)
7 diff
(98.8 %id)
BF733980 amnion_normal .q 1326 to 1710 391 to 4   tiling clone, Submitted on the opposite strand 388/393
(98 %)
7 diff
(98.3 %id)
BE302637 melanotic melanoma, skin .r 1 to 563 5 to 567   tiling clone,   567/567
(100 %)
1 diff
(99.9 %id)
Z44026 brain, total brain .r 1 to 339 2 to 340       340/340
(100 %)
1 diff
(99.8 %id)
CR604886 Placenta Cot 25-normalized .r 2 to 1796 1 to 1795 exact tiling clone,   1795/1795
(100 %)
0 diff
(100 %id)
BX361488 Placenta Cot 25-normalized .r 2 to 1015 1 to 1000   fully sequenced,   1000/1000
(100 %)
13 diff
(98.7 %id)
BE302638 melanotic melanoma, skin .r 5 to 610 1 to 607       607/619
(98 %)
9 diff
(98.6 %id)
BX361487 Placenta Cot 25-normalized .r 985 to 1771 834 to 28   fully sequenced,   737/764
(96 %)
43 diff
(94.4 %id)
AA300167 uterus .r 1311 to 1545 1 to 235       235/235
(100 %)
0 diff
(100 %id)
AW351837 colon .r 1325 to 1455 1 to 132       132/134
(98 %)
2 diff
(98.6 %id)
BE207486 melanotic melanoma, skin .r 1389 to 1909 544 to 23   AAA   522/523
(99 %)
22 diff
(95.8 %id)
BE208674 melanotic melanoma, skin .r 1418 to 1845 431 to 4       424/431
(98 %)
18 diff
(95.9 %id)
Z40076 brain, total brain .r 1635 to 1909 275 to 1   tiling clone,   275/275
(100 %)
1 diff
(99.7 %id)
AW411017 muscle, rhabdomyosarcoma .s 1 to 547 13 to 559   tiling clone,   555/559
(99 %)
6 diff
(99.0 %id)
CR593699 T cells (Jurkat cell line) .s 2 to 1767 1 to 1766 exact tiling clone,   1766/1766
(100 %)
0 diff
(100 %id)
BX426412 T cells (Jurkat cell line) .s 2 to 864 1 to 866   fully sequenced,   866/866
(100 %)
8 diff
(99.1 %id)
BX426411 T cells (Jurkat cell line) .s 830 to 1767 930 to 1   fully sequenced,   933/933
(100 %)
51 diff
(94.6 %id)
AW411018 muscle, rhabdomyosarcoma .s 1307 to 1794 507 to 20   tiling clone, AAA   488/488
(100 %)
3 diff
(99.4 %id)
AK302023 testis .t 1 to 1435 2 to 1436 T146A tiling clone,   1436/1436
(100 %)
1 diff
(100.0 %id)
DC304061 cerebellum .t 1 to 556 2 to 558       558/558
(100 %)
2 diff
(99.7 %id)
DC329756 corpus callosum .t 1 to 580 2 to 584   tiling clone,   584/584
(100 %)
5 diff
(99.2 %id)
DC396842 testis .t 1 to 575 2 to 576       576/576
(100 %)
1 diff
(99.9 %id)
DC315043 amygdala .t 9 to 567 1 to 559       559/559
(100 %)
0 diff
(100 %id)
DA078926 cerebellum .u 1 to 575 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA149638 amygdala .u 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA162190 amygdala .u 1 to 561 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA170915 amygdala .u 1 to 553 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA199893 brain .u 1 to 571 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA261883 caudate nucleus .u 1 to 583 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA273109 caudate nucleus .u 1 to 548 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA352595 substantia nigra .u 1 to 472 2 to 473   capped   472/472
(100 %)
1 diff
(99.8 %id)
DA380729 thalamus .u 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA563276 heart .u 1 to 564 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA713207   .u 1 to 523 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DA719732   .u 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA967113 stomach .u 1 to 571 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB248177 uterus .u 1 to 593 2 to 594   tiling clone, capped   593/593
(100 %)
0 diff
(100 %id)
DB249719 uterus .u 1 to 559 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA817338   .u 2 to 576 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CR594451 Placenta Cot 25-normalized .u 3 to 1958 1 to 1956 exact tiling clone,   1956/1956
(100 %)
0 diff
(100 %id)
BX356142 Placenta Cot 25-normalized .u 3 to 1030 1 to 1022   fully sequenced,   1022/1022
(100 %)
2 diff
(99.9 %id)
DA487318 brain .u 3 to 571 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CX166060 human embryonic stem cells differentiated toan early endodermal cell type .u 4 to 773 1 to 770       770/770
(100 %)
0 diff
(100 %id)
BX356141 Placenta Cot 25-normalized .u 969 to 1958 987 to 1   fully sequenced,   987/987
(100 %)
14 diff
(98.6 %id)
AK056242   .va 1 to 2644 2 to 2645 exact tiling clone, available from FLJ,   2645/2645
(100 %)
1 diff
(100.0 %id)
DA050716   .va 1 to 608 2 to 608   capped   607/607
(100 %)
1 diff
(99.9 %id)
DA702380   .va 1 to 463 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
DA782996 brain .va 1 to 555 2 to 557   capped   556/564
(98 %)
3 diff
(99.5 %id)
BX374972 Neuroblastoma Cot 25-normalized .va 15 to 827 1 to 813       813/813
(100 %)
1 diff
(99.9 %id)
BI831420 brain, medulla .va 437 to 1300 1 to 860   tiling clone,   860/864
(99 %)
22 diff
(97.5 %id)
DB323771   .va 2106 to 2644 539 to 1       539/539
(100 %)
0 diff
(100 %id)
BI117157 lung, small cell carcinoma .vb 1 to 665 5 to 682       682/854
(79 %)
27 diff
(96.9 %id)
BM544737 brain, hippocampus .vb 1 to 1011 25 to 1044   tiling clone,   1024/1089
(94 %)
32 diff
(97.1 %id)
BM544751 brain, hippocampus .vb 1 to 1009 21 to 1040   tiling clone,   1024/1059
(96 %)
28 diff
(97.4 %id)
BM910448 astrocytoma grade IV, cell line, brain .vb 1 to 857 4 to 871       868/1072
(80 %)
18 diff
(98.4 %id)
BG390981 embryonal carcinoma, cell line, testis .vb 1 to 713 3 to 713       713/713
(100 %)
2 diff
(99.8 %id)
BU501791 epithelioid carcinoma cell line, Pancreas .vb 4 to 860 1 to 856   tiling clone,   856/928
(92 %)
12 diff
(98.8 %id)
BE397252 Burkitt lymphoma, lymph .vb 16 to 677 1 to 663       663/777
(85 %)
10 diff
(98.8 %id)
BE267606 Burkitt lymphoma, lymph .vb 17 to 646 1 to 626       626/627
(99 %)
7 diff
(98.9 %id)
BE267874 Burkitt lymphoma, lymph .vb 17 to 652 1 to 631       631/633
(99 %)
10 diff
(98.5 %id)
BE269186 Burkitt lymphoma, lymph .vb 17 to 631 1 to 611       611/611
(100 %)
5 diff
(99.2 %id)
BE513877 Burkitt lymphoma, lymph .vb 17 to 664 1 to 647       647/661
(97 %)
7 diff
(99.0 %id)
BE560286 Burkitt lymphoma, lymph .vb 17 to 766 1 to 745       745/745
(100 %)
11 diff
(98.6 %id)
BG167235 hypernephroma, cell line, Kidney .vb 986 to 1724 1 to 727   tiling clone,   727/839
(86 %)
14 diff
(98.4 %id)
AW794506 uterus .vb 1149 to 1600 1 to 452   tiling clone,   452/452
(100 %)
13 diff
(97.2 %id)
BQ636419 eye, retina .vc 1 to 626 1 to 626   tiling clone,   626/626
(100 %)
1 diff
(99.9 %id)
BY798178 eye .vc 5 to 588 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BM924240 pooled colon, kidney, stomach .vc 5 to 1015 13 to 1032   tiling clone,   1020/1121
(90 %)
28 diff
(97.6 %id)
BQ927644 large cell carcinoma, lung .vc 20 to 938 1 to 927   tiling clone,   927/928
(99 %)
12 diff
(98.8 %id)
BQ955280 large cell carcinoma, lung .vc 20 to 827 1 to 809   tiling clone,   809/865
(93 %)
6 diff
(99.4 %id)
BE514789 adenocarcinoma cell line, ovary .vc 34 to 628 1 to 603       603/606
(99 %)
17 diff
(97.2 %id)
BG684697 B-cells, primary B-cells from tonsils (cell line) .vc 72 to 564 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BG686100 B-cells, primary B-cells from tonsils (cell line) .vc 72 to 883 1 to 809       809/857
(94 %)
7 diff
(99.2 %id)
BG677211 skin, squamous cell carcinoma .vc 177 to 876 1 to 701   tiling clone,   701/702
(99 %)
3 diff
(99.6 %id)
BF928451 nervous_tumor .vc 205 to 598 1 to 394       394/394
(100 %)
2 diff
(99.5 %id)
CU453855 epidermis .vc 240 to 776 544 to 8     Submitted on the opposite strand 537/556
(96 %)
1 diff
(99.9 %id)
AI052195 liver and spleen .vc 330 to 768 439 to 1       439/439
(100 %)
0 diff
(100 %id)
AW452639   .vc 990 to 1286 313 to 18   tiling clone, AAA   296/297
(99 %)
6 diff
(98.0 %id)
DA581452 lung .vd 1 to 562 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
BE295053 muscle, rhabdomyosarcoma .vd 95 to 750 1 to 657   tiling clone,   657/674
(97 %)
12 diff
(98.3 %id)
BM824181 Ascites, stomach .vd 737 to 1363 1 to 628   tiling clone,   628/628
(100 %)
1 diff
(99.9 %id)
AA745009 Ewing's sarcoma .vd 1095 to 1521 433 to 9   tiling clone,   425/449
(94 %)
0 diff
(100 %id)
BE162967 head_neck .vd 1410 to 1888 506 to 28     Submitted on the opposite strand 479/506
(94 %)
0 diff
(100 %id)
BP388992 pancreatic islet .vd 1459 to 1944 1 to 483   tiling clone, Submitted on the opposite strand 483/483
(100 %)
4 diff
(99.2 %id)
AL534668 brain, fetal brain .ve 1 to 1057 6 to 1051   tiling clone,   1051/1051
(100 %)
15 diff
(98.6 %id)
AW249085 lung, small cell carcinoma .ve 5 to 487 7 to 489   tiling clone,   483/489
(98 %)
6 diff
(98.8 %id)
BF928322 nervous_tumor .ve 833 to 1209 17 to 401       383/401
(95 %)
19 diff
(95.3 %id)
CR618133 Placenta Cot 25-normalized .ve 844 to 2231 1 to 1388   tiling clone,   1388/1388
(100 %)
0 diff
(100 %id)
BX379703 Placenta Cot 25-normalized .ve 844 to 1634 1 to 791   fully sequenced,   791/791
(100 %)
3 diff
(99.7 %id)
CA394070 eye, RPE/choroid .ve 1000 to 1549 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
AW383923 head_neck .ve 1063 to 1530 471 to 6       466/473
(98 %)
0 diff
(100 %id)
AW383944 head_neck .ve 1063 to 1542 479 to 2       478/481
(99 %)
0 diff
(100 %id)
BE155961 head_neck .ve 1063 to 1619 557 to 4     Submitted on the opposite strand 554/559
(99 %)
3 diff
(99.5 %id)
AA428806 ovarian tumor, ovary .ve 1066 to 1367 1 to 302       302/302
(100 %)
0 diff
(100 %id)
AW383932 head_neck .ve 1157 to 1542 1 to 385       385/385
(100 %)
22 diff
(94.3 %id)
AL534667 brain, fetal brain .ve 1258 to 2218 947 to 1       947/981
(96 %)
19 diff
(98.1 %id)
BE710891 head_neck .ve 1326 to 1538 214 to 2       213/214
(99 %)
0 diff
(100 %id)
BX379702 Placenta Cot 25-normalized .ve 1604 to 2231 628 to 1   fully sequenced,   628/628
(100 %)
11 diff
(98.3 %id)
AA429333 ovarian tumor, ovary .ve 1722 to 2259 536 to 1   tiling clone,   536/536
(100 %)
4 diff
(99.3 %id)
AW248650 lung, small cell carcinoma .ve 1834 to 2258 436 to 12   AAA   425/425
(100 %)
22 diff
(94.9 %id)
AK308795 brain .vf 1 to 1590 6 to 1595 exact tiling clone,   1595/1595
(100 %)
2 diff
(99.9 %id)
CN409828 embryonic stem cells, DMSO-treated H9 cellline .vf 1085 to 1556 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
AK297969   .vg 1 to 2010 2 to 2011   tiling clone,   2011/2011
(100 %)
0 diff
(100 %id)
DA578746   .vg 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB003278 breast, tumor tissue .vg 1 to 520 15 to 535   capped   521/521
(100 %)
2 diff
(99.7 %id)
DB201578 trachea .vg 1 to 576 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BM549836 leukocyte .vg 35 to 675 1 to 646       646/1118
(57 %)
16 diff
(98.6 %id)
CR610756 T cells (Jurkat cell line) Cot10-normalized .vh 1 to 1788 1 to 1788 exact tiling clone,   1788/1788
(100 %)
0 diff
(100 %id)
AL558937 T cells from T cell leukemia .vh 15 to 965 18 to 970       953/970
(98 %)
20 diff
(98.0 %id)
BX372044   .vh 599 to 1392 793 to 1       793/888
(89 %)
7 diff
(99.3 %id)
BG981337 colon_normal .vi-u 1 to 439 445 to 7   tiling clone,   439/445
(98 %)
0 diff
(100 %id)
BF987508 placenta_normal .vi-u 320 to 758 440 to 4   tiling clone,   437/450
(97 %)
0 diff
(100 %id)
BF987515 placenta_normal .vi-u 320 to 615 293 to 1       293/299
(97 %)
5 diff
(98.4 %id)
BF954541 nervous_normal .vi-u 332 to 733 405 to 5       401/405
(99 %)
0 diff
(100 %id)
BF954542 nervous_normal .vi-u 332 to 830 506 to 11   tiling clone,   496/506
(98 %)
0 diff
(100 %id)
BG913428 anaplastic oligodendroglioma with 1p/19qloss, brain .vj 1 to 600 1 to 603 Y60I Q61R M62W A63P H64T ... tiling clone,   603/603
(100 %)
10 diff
(98.4 %id)
BG743654 skin .vk 1 to 795 1 to 800 exact tiling clone,   800/801
(99 %)
14 diff
(98.3 %id)
BM923632 pooled colon, kidney, stomach .vk 95 to 969 1 to 881       881/1052
(83 %)
22 diff
(98.0 %id)
BM479682 eye, retinoblastoma .vk 143 to 1096 1 to 956   tiling clone,   956/1018
(93 %)
10 diff
(99.1 %id)
DA888644   .vl 1 to 563 2 to 565   tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
BC018471 Breast, mammary adenocarcinoma. .vl 48 to 776 1 to 729 exact tiling clone, available from MGC, AAA   729/729
(100 %)
0 diff
(100 %id)
BG577337 breast, mammary adenocarcinoma, cell line .vl 49 to 494 1 to 452   available from MGC,   451/452
(99 %)
19 diff
(95.8 %id)
TI_1948099081   .vl 63 to 551 129 to 617       489/515
(94 %)
6 diff
(98.9 %id)
CV029817 mixed .vl 64 to 632 1 to 569       569/605
(94 %)
1 diff
(99.9 %id)
TI_1948099224   .vl 65 to 622 126 to 683       558/593
(94 %)
9 diff
(98.5 %id)
TI_57163127   .vl 162 to 782 47 to 667   AAA   620/667
(92 %)
10 diff
(98.6 %id)
BI838488 pooled pancreas and spleen .vl 163 to 782 1 to 620   AAA   620/620
(100 %)
4 diff
(99.4 %id)
DB445881 testis .vm 1 to 462 1 to 462 T132K T147K tiling clone,   462/462
(100 %)
3 diff
(99.4 %id)
AW086244 pooled .vn 1 to 255 274 to 20   tiling clone,   255/286
(89 %)
0 diff
(100 %id)
BM543982 ovary (pool of 3) .vn 41 to 979 29 to 970   tiling clone,   942/1133
(83 %)
33 diff
(97.1 %id)
AW953456   .vn 268 to 987 11 to 729   tiling clone,   719/729
(98 %)
6 diff
(99.2 %id)
Z43955 brain, total brain .vn 268 to 478 1 to 211       211/211
(100 %)
0 diff
(100 %id)
T08707   .vn 268 to 682 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
CN409830 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vn 939 to 1586 1 to 649 S127F Y128I F129L R130Q A131G ... tiling clone,   649/649
(100 %)
1 diff
(99.9 %id)
BQ321075 colon .vn 1076 to 1233 174 to 18       157/182
(86 %)
0 diff
(100 %id)
BQ321079 colon .vn 1076 to 1233 174 to 18       157/182
(86 %)
0 diff
(100 %id)
AW381770 head_neck .vn 1090 to 1232 152 to 11       142/152
(93 %)
0 diff
(100 %id)
AW582506 stomach .vn 1090 to 1232 159 to 19       141/159
(88 %)
0 diff
(100 %id)
AW817068 stomach .vn 1090 to 1290 227 to 20       208/227
(91 %)
0 diff
(100 %id)
AW817195 stomach .vn 1090 to 1227 153 to 15       139/153
(90 %)
0 diff
(100 %id)
AW817513 stomach .vn 1090 to 1228 1 to 138       138/138
(100 %)
1 diff
(99.3 %id)
BE155771 head_neck .vn 1090 to 1232 159 to 17     Submitted on the opposite strand 143/159
(89 %)
0 diff
(100 %id)
BE843022 stomach .vn 1090 to 1243 153 to 1       153/153
(100 %)
2 diff
(98.7 %id)
DA273234 caudate nucleus .vo 1 to 559 5 to 563 exact tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DB109467 thymus .vp 1 to 576 7 to 582 exact tiling clone, capped   581/581
(100 %)
1 diff
(99.9 %id)
DQ655944   .vq 1 to 680 1 to 680 exact tiling clone,   680/681
(99 %)
2 diff
(99.8 %id)
DQ655943   .vq 4 to 686 8 to 691       684/737
(92 %)
34 diff
(95.4 %id)
H22880 whole brain .vr 1 to 375 1 to 380   tiling clone,   380/523
(72 %)
12 diff
(97.8 %id)
BE825216 colon_normal .vr 8 to 387 385 to 3   tiling clone,   383/386
(99 %)
2 diff
(99.5 %id)
BI015459 lung_tumor .vr 332 to 488 170 to 12   tiling clone,   159/173
(91 %)
0 diff
(100 %id)
DB151363 thymus .vs 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
2 diff
(99.7 %id)
DA333044 hippocampus .vs 170 to 759 2 to 590   tiling clone, capped   589/589
(100 %)
1 diff
(99.9 %id)
DA369007 subthalamic nucleus .vs 289 to 799 2 to 512   tiling clone, capped   511/514
(99 %)
5 diff
(99.1 %id)
AK091049 brain .vs 406 to 3058 1 to 2651 exact tiling clone, available from FLJ,   2651/2651
(100 %)
2 diff
(100.0 %id)
DA209732 brain .vs 407 to 977 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
CN315406 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vs 694 to 1298 16 to 621       606/621
(97 %)
6 diff
(99.1 %id)
DA375588 thalamus .vs 920 to 1444 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DA255783 caudate nucleus .vs 1032 to 1534 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
CX871955 embryonic stem .vs 1294 to 1979 1 to 686   tiling clone,   686/686
(100 %)
0 diff
(100 %id)
DA361547 subthalamic nucleus .vs 1320 to 1859 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
BF087847 head_neck .vs 1831 to 2010 1 to 180       180/180
(100 %)
0 diff
(100 %id)
DB304337 brain .vs 2521 to 3058 538 to 1       538/538
(100 %)
0 diff
(100 %id)
DB311130 thalamus .vs 2539 to 3056 518 to 1       518/518
(100 %)
0 diff
(100 %id)
CA487758   .vt-u 1 to 697 1 to 704   tiling clone,   704/918
(76 %)
22 diff
(97.7 %id)
CN409815 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vt-u 210 to 725 1 to 516 exact     516/516
(100 %)
2 diff
(99.7 %id)
AW371547 breast .vt-u 282 to 696 6 to 416       411/416
(98 %)
6 diff
(98.6 %id)
AW609771 stomach .vt-u 291 to 724 12 to 445 W24R     434/445
(97 %)
6 diff
(98.7 %id)
AW609779 stomach .vt-u 293 to 565 13 to 286       274/286
(95 %)
6 diff
(98.0 %id)
AW601246 breast .vt-u 295 to 583 1 to 299       299/299
(100 %)
14 diff
(95.4 %id)
AW817369 stomach .vt-u 295 to 724 1 to 429 G13S L14S T47S     429/429
(100 %)
7 diff
(98.4 %id)
AW817435 stomach .vt-u 295 to 724 430 to 1 M74V D114G     430/430
(100 %)
3 diff
(99.4 %id)
BF375446 stomach .vt-u 300 to 658 54 to 411       358/411
(87 %)
6 diff
(98.6 %id)
AW609773 stomach .vt-u 301 to 565 1 to 265       265/265
(100 %)
0 diff
(100 %id)
AW609774 stomach .vt-u 301 to 724 1 to 424 A46G     424/424
(100 %)
1 diff
(99.8 %id)
AW609778 stomach .vt-u 301 to 724 1 to 424 exact     424/424
(100 %)
0 diff
(100 %id)
AW609785 stomach .vt-u 301 to 724 424 to 1 Q98*     424/424
(100 %)
4 diff
(99.1 %id)
AW609813 stomach .vt-u 301 to 724 425 to 1 D80G     425/425
(100 %)
3 diff
(99.3 %id)
AW609814 stomach .vt-u 301 to 724 424 to 1 R104Q P123R     424/424
(100 %)
2 diff
(99.6 %id)
AW609840 stomach .vt-u 301 to 565 264 to 1       264/264
(100 %)
2 diff
(99.3 %id)
AW609860 stomach .vt-u 301 to 526 1 to 225       225/225
(100 %)
2 diff
(99.2 %id)
AW817154 stomach .vt-u 301 to 724 1 to 425 G13E L14F G15R G16R G17R ...     425/425
(100 %)
2 diff
(99.6 %id)
AW817166 stomach .vt-u 301 to 724 1 to 424 G13A L14F G15R G16R G17R ...     424/424
(100 %)
3 diff
(99.3 %id)
AW817288 stomach .vt-u 301 to 565 1 to 264       264/264
(100 %)
6 diff
(97.8 %id)
AW817436 stomach .vt-u 301 to 721 423 to 3 exact     421/423
(99 %)
0 diff
(100 %id)
AW817437 stomach .vt-u 301 to 565 1 to 266       266/266
(100 %)
2 diff
(99.3 %id)
AW817441 stomach .vt-u 301 to 724 1 to 424 exact     424/424
(100 %)
0 diff
(100 %id)
AW817495 stomach .vt-u 301 to 565 275 to 12       264/275
(96 %)
0 diff
(100 %id)
AW817500 stomach .vt-u 301 to 655 7 to 361       355/361
(98 %)
0 diff
(100 %id)
AW601250 breast .vt-u 315 to 567 2 to 255       254/261
(97 %)
7 diff
(97.4 %id)
TI_154112254   .vt-u 373 to 1170 875 to 84   tiling clone, AAA   792/958
(82 %)
11 diff
(98.9 %id)
DA205632 brain .vu-u 1 to 584 2 to 585   tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
DB027046 testis .vu-u 62 to 614 2 to 555 I43D N44Q S45L T46N P47T ... tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
DB050396 testis .vv 1 to 550 2 to 551 exact tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
BM469451 embryonal carcinoma, cell line, testis .vw 1 to 876 1 to 886 exact tiling clone,   886/1031
(85 %)
18 diff
(98.3 %id)
R94276 liver and spleen .vx 1 to 376 1 to 376 G20X F28X H76S tiling clone,   376/436
(86 %)
10 diff
(97.8 %id)
BQ574430 Chondrosarcoma Grade II, Left Pelvis .vx 192 to 1010 829 to 19   tiling clone, AAA   811/811
(100 %)
9 diff
(98.9 %id)
BE843026 stomach .vx 245 to 561 319 to 3       317/319
(99 %)
0 diff
(100 %id)
AI885518 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vx 301 to 1010 709 to 1       709/709
(100 %)
17 diff
(97.7 %id)
AV693784 hepatocellular carcinoma .vx 328 to 735 1 to 403       403/406
(99 %)
9 diff
(97.8 %id)
CA448563 Chondrosarcoma, Left Pelvis .vx 339 to 1010 690 to 19   AAA   672/672
(100 %)
0 diff
(100 %id)
BE085690 breast .vx 346 to 630 285 to 4     Submitted on the opposite strand 282/294
(95 %)
0 diff
(100 %id)
BF373199 prostate_tumor .vx 353 to 633 277 to 1       277/277
(100 %)
10 diff
(96.4 %id)
BM987358 Bone, Subchondral Bone .vx 353 to 1010 675 to 19   AAA   657/657
(100 %)
1 diff
(99.9 %id)
AW817497 stomach .vx 378 to 503 10 to 135       126/135
(93 %)
14 diff
(89.7 %id)
BE843014 stomach .vx 404 to 564 1 to 160       160/160
(100 %)
2 diff
(98.8 %id)
BI772106 pooled lung and spleen .vx 415 to 683 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
BI771245 pooled lung and spleen .vx 416 to 683 1 to 268       268/268
(100 %)
1 diff
(99.7 %id)
AW867967 stomach_normal .vx 417 to 978 567 to 6       562/567
(99 %)
0 diff
(100 %id)
AA225011   .vx 500 to 920 1 to 421       421/421
(100 %)
5 diff
(98.9 %id)
DB550171 hippocampus .vx 533 to 1010 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
BI003184 head_normal .vx 563 to 953 387 to 8       380/389
(97 %)
0 diff
(100 %id)
AA225055   .vx 587 to 1012 432 to 4   tiling clone,   429/432
(99 %)
0 diff
(100 %id)
EL595124 epidermis, skin .vx 626 to 979 381 to 28     Submitted on the opposite strand 354/404
(87 %)
0 diff
(100 %id)
BG232013 blood, lymphocyte .vx 641 to 1010 390 to 21   AAA   370/370
(100 %)
2 diff
(99.5 %id)
R94629 liver and spleen .vx 701 to 983 284 to 1       284/284
(100 %)
8 diff
(97.2 %id)
DB061773 testis .vy 1 to 579 2 to 580 exact tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
BU849238 ovary, teratocarcinoma, cell line .vz 1 to 857 1 to 859 exact tiling clone,   859/862
(99 %)
5 diff
(99.5 %id)
BX437580 thymus .vz 128 to 963 1 to 836 exact tiling clone,   836/836
(100 %)
0 diff
(100 %id)
CT003577 T-Lymphocytes .wa 1 to 611 1 to 611   tiling clone,   611/613
(99 %)
4 diff
(99.4 %id)
AA308918 colon .wa 304 to 703 1 to 400 V31I tiling clone,   400/400
(100 %)
2 diff
(99.5 %id)
CB996450 placenta, pre-eclamptic placenta .wb 1 to 633 23 to 662 H2D G40R V58A R125G tiling clone,   642/835
(76 %)
24 diff
(97.2 %id)
DQ655946   .wc 1 to 619 1 to 619 Y30H M41L tiling clone,   619/638
(97 %)
10 diff
(98.5 %id)
DB060608 testis .wd 1 to 582 2 to 583   tiling clone, capped   582/582
(100 %)
0 diff
(100 %id)
DA098101 cerebellum .wd 50 to 604 2 to 557 T16D M17H D18G I19H R20S ... tiling clone, capped   556/556
(100 %)
2 diff
(99.7 %id)
DA474803   .we 1 to 564 2 to 565 exact tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
FN120228 breast carcinoma .we 23 to 100 78 to 1     Submitted on the opposite strand 78/81
(96 %)
0 diff
(100 %id)
DB450484 testis .wf-u 1 to 341 1 to 342 P2A A10G H15K Q20K tiling clone,   342/384
(89 %)
12 diff
(96.9 %id)
BF803694 colon_ins .wf-u 134 to 424 290 to 1   tiling clone, Submitted on the opposite strand 290/290
(100 %)
2 diff
(99.4 %id)
BF964136 nervous_normal .wg-u 1 to 277 284 to 5 exact tiling clone,   278/284
(97 %)
0 diff
(100 %id)
539 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi-u, .vj, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs, .vt-u, .vu-u, .vv, .vw, .vx, .vy, .vz, .wa, .wb, .wc, .wd, .we, .wf-u, .wg-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI